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ABTRACT 
 
 
Cells movements and cell fate decision occurring during embryonic development are ruled by 
several chemical signals genetically encoded. Some of them are known as morphogens, because 
they create a gradient along the embryo and stimulate a different cell response depending on the 
concentration detected by each cell. BMP, TGFb, Wnt and Shh are actually recognized as 
chemical signals acting as morphogens. In the responsive cells, these extracellular signals trigger 
a signal transduction pathway that leads to the activation of specific transcription factors. In 
adult, they are also important to maintain the tissue homeostasis and to regulate the regeneration 
processes. It has been demonstrated that their deregulation is associated to some diseases, such 
as cancer and some pathologies associated to an altered inflammatory response.  
Zebrafish can be a useful tool to study these pathways. The transparency of the embryo and the 
external fertilization that make possible both chemical and genetic manipulations are some of the 
advantages of this experimental model. Our lab has developed some transgenic reporter lines to 
study in vivo morphogens signalling. The aim of this thesis has been to characterize and validate 
these reporter lines, especially the smad3/TGFb-responsive line.  
After having demonstrated that these lines are faithfully responsive to the correspondent 
pathway, they have been used for two main projects: 
- to understand the role of smad3 during the central nervous system (CNS) development 
- to study the interaction occuring among the morphogens together with Notch and FGF 
signalling in early larval development 
It has been demonstrated that smad3-associated reporter expression is localized in the inner part 
of the CNS, where neural progenitor cells are situated. Notably, colocalization measurment with 
reporter genes expressed in various neural markers have demonstrated that smad3 is active in 
both glial and neuronal precursor cells. Furthermore, both chemical inhibition and smad3 knock-
down cause a decrease of precursors accompanied to an increase of progenitor, and a reduction 
of mature cells, such as motor neurons and oligodendrocytes. EdU proliferation assay has 
confirmed that smad3 is active in post-mitotic, non proliferating cells and smad3/TGFb 
inhibition leads to an increase of cell proliferation and an altered epithelial-to-mesenchymal 
transition that can be responsible of the observed motor neuron misalignment. Both Zebrafish 
smad3 paralogues, smad3a and 3b, seem to play a similar role in the CNS development as 
knock-down of each isoform impairs neural differentiation. 
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To study epistatic interactions, reporter lines embryos have been treated at 24 hpf with drugs 
specifically acting on the 4 studied morphogen pathways, Notch and FGF signalling. The effects 
of treatments have been initially recorded with the epifluorescent microscope. Results have been 
associated to those inferred by GFP mRNA in situ hybridization performed on the reporter larvae 
treated with the same drugs as before. To have reliable data, fluorescence levels have been 
quantified for each group of treatment through ImageJ software. Results obtained have been used 
to infer possible interactions among the observed chemical signals at early larval development. A 
confocal analysis of double reporter transgenic larvae has confirmed the relative expression of 
the signalling pathways. 
As a further demonstration of the possibility of an in vivo use of Zebrafish transgenic lines, a 
preliminary study concerning the role of morphogens on pancreas development has been 
performed. Crossing the morphogens lines with transgenics expressing a reporter gene in 
endocrine or exocrine pancreas, in either progenitors or precursors, it has been possible to reveal 
a new involvement of Shh signalling in the pancreatic islet at early larval development and the 
activity of BMP pathway in pancreatic vasculature, where it seems to play a role in the correct 
positioning of the main islet and control angiogenesis, as demonstrated by functional studies. 
In conclusion, the morphogen reporter lines here described can represent interesting 
experimental models in different biological fields. They permit to follow dynamic processes both 
in physiological and pathological conditions in vivo. They are faithfully responsive to the studied 
signalling and can be a complementary tool to the current in vitro studies. 
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INTRODUCTION 
 
 
1. Zebrafish as a model for in vivo study: developmental biology, genetics, pharmacology 
and physiopathology 
In the last decades Zebrafish (Danio renio) has become a useful model for studies of genetic, 
developmental biology and pharmacology. Its small size, short generation time (roughly three 
months), relatively easy breeding and reproduction and the large amount of embryos obtained 
from each female (roughly 200 eggs per female) represent some of the positive aspects that make 
Zebrafish a fascinating model for physiological and pathological processes (Moro et al., 2013). 
Another of the biggest advantages of Zebrafish is represented by the external fertilization that 
makes possible any genetic and chemical manipulations. Furthermore, due to its extra-uterine 
development and its tissues transparency any morphological modifications of the organs can be 
follow in vivo at the microscope using either transient or stable reporter expression (Moro et al., 
2013). 
 
1.a Transgenic reporter lines: how to study gene activity in vivo 
The transparency of Zebrafish embryo and the relatively easy genetic manipulations have 
permitted the generation of several transgenic lines. By cloning a reporter gene (i.e., GFP, CFP, 
mCherry, YFP and so on) under the control of a gene promoter it is possible to study in vivo how 
the expression of this target gene change temporally and spatially in a living animal. 
Furthermore, the reporter gene expression can be directed by repeated sequences that are 
responsive to a specific transcription factor. This let us study a dynamic process in normal and 
altered conditions (mutant background, drug treatment, morpholino knock-down) and in relation 
with other processes (creating double transgenics).  
Our lab has produced some transgenic reporter lines to study four morphogens: BMP, TGF-beta, 
Wnt and Shh.  
Briefly, a polymerized repeated sequence corresponding to the cis element bound by the 
transcription factor acting at the bottom of the signal is cloned upstream to a minimal promoter 
and a reporter gene. These sequences have been cloned in a Tol2-vector, a transposone-donor 
plasmid, that is microinjected in Zebrafish embryos at 1-2 cell stage together with mRNA 
enconding for a transposase necessary for excision and recombination of the Tol2-vector into the 
host genome (Fig. 1). The efficacy of this method of transgenesis can reach 70 % (Moro et al., 
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2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Here follows a description of the chemical signal transduction pathways studied in this thesis. 
The corresponding reporter lines will be presented on the next chapter (Results). 
 
 
2. Genetic signals involved in embryonic development: BMP, TGF-beta, Shh, Wnt and 
Notch 
 
2.1 Morphogens 
The concept of morphogen has been introduced some decades ago to explain how cells migrate 
during the embryonic development and why they adopt a cell fate instead of another one. 
Fig. 1. Rappresentative scheme 
of the generation of a 
transgenic reporter line. 
Regulatory elements (RE) can be 
found in litterature and/or 
through in silico analysis. These 
sequence are polymerized to 
increase the sensibility of the 
future reporter line and cloned 
upstream of a reporter gene 
together with a minimal 
promoter and a poly-A site. For 
Tol-2 transgenesis, a pDestTol2 
vector is injected into fertilized 
eggs with a transposase mRNA. 
The injected embyos are selected 
for the reporter expression and 
grown to adulthood. These fishes 
are then screened to find  a 
founder of a stable reporter 
integration (Moro et al., 2013).  
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Morphogens are also important for a proper tissue patterning (Charron and Tessier-Lavigne, 
2007). The concept of morphogen relies on the presence of a chemical extracellular signal 
released by a group of cells called organiser (Kodjabachian, 2001). This signal forms a 
concentration gradient along the embryo body triggering a different response in the receiving 
cells depending on their distance from the emitting organiser. Nowadays, four chemical signals 
have been identified as morphogens: Transforming Growht Factor-beta (TGFb)/Bone 
Morphogenetic Proteins (BMP), Sonic hedgehog (Shh) and Wnt (Charron and Tessier-Lavigne, 
2007).   
 
2.1a TGFb superfamily: BMP and TGFb 
TGFb and BMP signalling belong to the TGFb-superfamily. Both morphogens show a similar 
transduction pathway. The secreted ligands interact with type I and II transmembrane serine-
threonine kinases receptors. The type II receptors phosphorylate type I receptor, which in turn 
permits the binding of receptor-regulated transcription factors smads (r-smads) and their 
following phosphorylation at the C-terminus. Activated r-smads can interact with a common 
mediator smad or co-smad (smad4) and then translocate into the nucleus to direct target gene 
expression (Fig. 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. TGFb and BMP signalling pathways. BMP and TGFb share a similar transduction pathway   
Secreted ligands bind to type II serine/treonine kinase receptors that activate type I receptors. This 
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receptor complex activate r-smads transcription factors, that together with smad4 transcription factor 
translocate to the nucleus where they coordinate the target gene expression. Both BMP and TGFb can 
activate smad-indipendent cascades (MAPK signallling) (Villapol et al., 2013). 
 
BMP pathway  
Bone Morphogenetic Proteins (BMPs) were initially identified for their ability to induce bone 
regeneration. They are a large subgroup (more than 20 members) of the transforming growth 
factor-beta (TGFb) super family. They are expressed in many tissues under physiologic 
conditions and are regulated through extracellular antagonists, like noggin, chordin, follistatin 
and DAN. BMPs are divided into several subgroups according to sequence similarities and 
homology (Wen et al., 2009). The action of BMP is mediated by heterotetrameric 
serine/threonine kinase receptors. There are two specific BMP receptor subunits, BMPRI (BMP 
Receptor Type-I) and BMPRII, which are required for high-affinity binding. The binding of 
BMP ligands leads to BMPRI activation and then smad1, 5 and 8 phosphorylations. The 
phosphorylated BMP-specific smads form a complex with the co-smad or smad4 and then 
translocate into the nucleus to activate transcription of specific genes by binding with the GCCG 
motif in the promoter regions of many BMP-responsive genes (Wen et al., 2009). They are also 
recruited to the promoters of BMP-responsive genes by cofactors such as OAZ, which binds to 
the promoter of STAT3, leading to the transactivation of the glial fibrillary acidic protein gene 
(GFAP), a marker for astroglial differentiation (Wen et al., 2009).  
BMPs are involved in many developmental processes, including cell proliferation, 
differentiation, apoptosis and intercellular interactions during morphogenesis. In the ectoderm, 
BMPs activate two biochemical pathways, one mediated by smads and the other mediated by the 
p38/MAPK (mitogenactivated protein kinase) pathway downstream of TAK1 (TGFb activated 
kinase-1) (Wen et al., 2009). 
During embryogenesis, BMP signalling forms an antero/posterior and dorso/ventral gradients 
along the embryo body (Hashiguchi and Mullins, 2013) and it also regulates the left to right 
asymmetry (Luo and Su, 2012). BMP is important at the end of gastrulation to specify the 
ventral-posterior patterning, that in zebrafish leads to the formation of the cloaca (Pyati et al., 
2006).  
 
TGFb pathway  
BMP and TGFb signalling require different ligands (GDF and BMP ligands for BMP, activin, 
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nodal and properly-said TGFb ligands for TGFb), type II receptors (Alk1, 2, 3 and 6 for BMP 
and Alk4, 5 and 7 for TGFb) and r-smads (smad1, 5 and 8 for BMP and smad2 and 3 for TGFb) 
(Hinck, 2012). As a consequence, r-smads-recognized gene sequences are different for the two 
signalling.  
For Zebrafish two smad3 isoforms are known: smad3a and 3b. They are the results of the 
genome duplication occurred during teleost evolution. These two genes show a partially 
overlapping expression: they are both expressed in tail bud and lateral stripes of the forming 
mesoderm, however, smad3a is also produced in an additional area that surrounds the tail bud 
(Dick et al., 2000). Their general cellular mechanisms of action are similar and they are 
expressed in overlapping and not overlapping tissues (Pogoda and Meyer, 2002) displaying 
additive genetic effects. 
All the receptor-regulated smads and smad4 are ubiquitously expressed since blastula stage as a 
consequence of their maternal origin (Dick et al., 2000). During gastrulation, all the receptor-
activated smads are either present at very low level (smad2), or quite undetectable (smad3a and 
3b) (Dick et al., 2000) (Pogoda and Meyer, 2002). In contrast, smad4 expression is maintained at 
a high rate in all this stage (Dick et al., 2000). From tail bud smad3a and 3b production rises up 
(Hsu et al., 2011). At late somitogenesis (16 hpf) smad3a is confined to the eyes and tail region, 
although it is present throughout the embryo at low level. Smad3b is expressed in the same areas, 
but it has a higher ubiquitous expression. Both smad2 and 4 are present in the entire embryo with 
a higher level in tail region, eye and brain (Hsu et al., 2011). However, smad2 and 3 expression 
is necessary but not sufficient for a function since a signal transduction cascade leading to their 
phosphorylation is needed (Liu et al., 1997). 
R-smads activity is regulated by inhibitory-smads (i-smad). For TGFb smad7 functions as 
negative signalling regulator. The inhibitory transcription factor smad7 is induced by smad3 and 
provides a negative feedback loop to the pathway. Smad7 shows a pattern of expression similar 
to that observed for smad3b, underlying the reciprocal functional connection between the 2 
genes. Smad7 is ubiquitously present as maternal transcript until gastrula stage, when its 
expression falls down, becoming limited to the ventral side of the embryo, while its expression 
increases in the tail bud (Pogoda and Meyer, 2002). Smad7 can act in different ways: it can 
compete to r-smads for binding type I receptors; it can recruit E3-ubiquitine ligases (Smurf1 and 
2) to the activated type I receptors causes its degradation (ten Dijke and Hill, 2004).  
TGF-beta signalling is involved in a wide range of physiological and pathological processes both 
in embryonic and adult stage. It acts as a morphogen through Nodals and Activins directing the 
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patterning of the three germ layers (Watabe and Miyazono, 2009). A disregulation of this 
pathway is associated to tumorigenesis, fibrosis, allergy and neurodegenerative diseases. Both in 
physiological and pathological conditions, its effects depend on its tight regulation of the cell 
cycle (Fleisch et al., 2006).  
TGFb signalling is a well-known pro-apoptotic signal and promotes epithelial-to-mesenchymal 
transition (EMT), too (Song, 2007). However, these events seem to be mutually exclusive. It has 
been demonstrated that TGF-b1-induced G1/S phase growth arrest may provide cells a 
precondition for undergoing EMT, whilst TGF-b1 induces apoptosis in cells at G2/M phase 
(Song, 2007). As a matter of facts, smad4 is a powerful tumour suppressor in pancreatic tumours 
(Herman et al., 2013). 
 
2.1b Shh signalling 
Sonic hedgehog (Shh) is a member of the hedgehog family together with Indian hedgehog (Ihh) 
and desert hedgehog (Dhh). Before to be secreted, Shh precursor protein is cleaved to yield a ~19 
kDa N-terminal domain (signaling domain; N-Shh) and a ~25 kDa C-terminal domain (catalytic 
domain). The canonical Hedgehog signalling is mediated by two transmembrane proteins, a 
twelve-pass membrane protein Patched (Ptc) and a seven-pass membrane protein Smoothened 
(Smo). When Shh is absent, Ptc acts as a transcriptional repressor, interacting with Smo. When 
Shh binds Ptc, this transmembrane receptor releases Smo, leading to the nuclear translocation of 
Gli proteins as transcriptional activators (Fig. 3). There are three Gli genes with different 
functions in vertebrates. The target genes of Shh signalling include proliferation-related genes N-
Myc, cyclin D1, E2f1 and E2f2 and those involved in de novo vascularization during embryonic 
development such as all three VEGF-1 (vascular endothelial growth factor-1) isoforms and 
angiopoietins-1 and -2 (Oliver et al., 2003).  
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Fig. 3. Shh signalling pathway. HH ligands bind to patched 1 (PTC1) that releases repression of 
smoothened (SMO), enabling Gli translocation to the nucleus where it acts as a transcription factor to 
induce gene expression (Baker and McKinnon, 2004). 
 
Shh is involved in the determination of cell fate and embryonic patterning during early vertebrate 
development. It patterns the ventral side of neural tube and somites and it is involved in the left 
to right asymmetry (Howie and Fisher, 2008) 
 
2.1c Wnt/beta-catenin signalling 
Three different Wnt signalling transduction pathways can be distinguished: the canonical Wnt 
pathway, the noncanonical planar cell polarity pathway and the noncanonical Wnt/calcium 
pathway.  
In canonical Wnt pathway, interactions of Wnt proteins with other components, beta-catenin, 
adenomateous polyposis coli (APC), glycogen synthase kinase-3β (GSK-3β), Axin and 
Conductin, orchestrate cell proliferation and differentiation during embryogenesis. If Wnt 
pathway is not active, the excess of β-catenin in cytoplasm is phosphorylated by a complex 
formed by GSK-3β, Axin, Conductin and APC, and leads to degradation by the ubiquitin 
proteasome system. Activation of Wnt signalling pathway leads to inhibition of GSK-3β, 
resulting in accumulation of β-catenin, that enter to the nucleus. Wnt signalling activation is 
achieved if β-catenin moves into the nucleus and complexes with T-cell factors (TCFs) and/or 
lymphocyte enhance factors (LEFs) to activate transcription of target genes (Fig. 4). 
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Fig. 4. Wnt signalling pathway. In the canonical Wnt/β-catenin signalling, Frizzled (Fz) binds Wnt 
ligands and activates Dishevelled (Dsh). Then Dsh inhibits blocks the beta-catenin destruction complex 
(adenomatous polyposis coli (APC), axin, and glycogen synthase kinase-3 (GSK-3)), which 
phosphorylates β-catenin in the absence of the ligands. beta-Catenin is stabilized and translocated to the 
nucleus, where it recruits transactivators proteins of the lymphoid enhancer factor/T cell factor 
(LEF/TCF) family. (Baker and McKinnon, 2004). 
 
The noncanonical planar cell polarity (PCP) pathway is one of the two Wnt pathways that does 
not involve β-catenin. As in the canonical Wnt pathway, the PCP pathway is activated via the 
binding of Wnt to Fz and its co-receptor. The receptor then recruits Dishevelled (Dsh), which 
forms a complex with Dishevelled-associated activator of morphogenesis-1 (Daam1). Daam1 
then activates the small G-protein Rho through a guanine exchange factor. Rho activates Rho-
associated kinase (ROCK), which is one of the major regulators of the cytoskeleton. Dsh also 
forms a complex with rac1 and mediates profilin binding to actin. Rac1 activates JNK and can 
also lead to actin polymerization (Sugimura and Li, 2010).  
The noncanonical Wnt/calcium pathway is the last Wnt pathway that does not stimulate 
accumulation of β-catenin. Its role is to help regulate calcium release from the endoplasmic 
reticulum (ER) in order to control intracellular calcium levels. Like other Wnt pathways, upon 
ligand binding, the activated Fz receptor directly interacts with Dsh and activates specific Dsh-
protein domains. Unlike the other Wnt pathways, the Fz receptor also directly interfaces with a 
trimeric G-protein. This co-stimulation of Dsh and the G-protein can lead to the activation of 
either phospholipase C (PLC) or cGMP-specific PDE. If PLC is activated, the plasma membrane 
component phosphatidyl inositol 2-phosphate (PIP2) is cleaved into diacyl glycerol (DAG) and 
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inositol-3 phosphate (IP3). When IP3 binds its receptor on the ER, calcium is released (Komiya 
and Habas, 2008).  
Wnt pathway is one of the most studied posteriorizing signals (Caneparo et al., 2007). In fact, 
increase of Wnt signalling in embryos at gastrula stage impairs the development of rostral neural 
identity and causes a posterior transformation of the anterior neural plate (Caneparo et al., 2007). 
A variety of molecules, acting as secreted antagonists of the Wnt pathway, have been identified 
in the Spemann Organizer. Most of them are related to the extracellular domain of the Wnt 
receptor Frizzled and act by direct binding to Wnt proteins (Caneparo et al., 2007).  
 
2.2 Notch signalling  
The Notch proteins are 300-kDa transmembrane receptors, which function in CNS development 
by guiding cell fate determination. Four Notch receptors (Notch1-Notch4) and five structurally 
similar Notch ligands, Delta 1, Delta 3, Delta 4, Jagged 1 and Jagged 2, have been identified in 
mammals. The extracellular domain of the two transmembrane ligands, delta and serrate 
(jagged), interacts with the extracellular domain of Notch receptor on the adjacent cell. This 
ligand binding induces a sequence of proteolytic events that leads to the cleavage of Notch and, 
consequently, the generation of Notch intracellular domain (NICD). NICD translocates into the 
nucleus and then associates with the constitutive DNA binding protein CSL (CBF1, Suppressor 
of hairless, Lag-1), that is switched from a transcriptional repressor to a transcriptional activator 
(Fig. 5). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Notch signalling pathway. Notch ligands (Delta and Jagged) bind to Notch receptors causing a 
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double proteolytic cleavage. The first is mediated by ADAM family metalloprotease, that cut the 
extracellular domain of the receptor. Then, another enzyme, gamma-secretase or presenilin (PS) cleaves 
the intracellular domain (NICD),  that can enter the nucleus and direct the gene expression with various 
transcription factors (revfrost.files.wordpress.com). 
 
The Notch signalling involves adjacent cells communicating with each other. Its effects do not 
depend on a concentration gradient, therefore it cannot be considered a morphogen. It is 
considered as a juxtacrine pathway that defines borders between cells and tissue types and it is 
possible that regulates the subdivision of the endoderm and mesoderm during gastrulation 
(Miazga and McLaughlin, 2009). All multicellular animals utilize this pathway, which 
contributes to the embryogenesis. In fact, it promotes different processes, such as neurogenesis, 
somitogenesis, myogenesis, and so on.  
 
 
3. Neurogenesis in Zebrafish 
The development of CNS begins as a sheet of cells made up of primary progenitors known as 
neuroepithelial cells. These cells are then substituted by different neural stem cells (NSCs).  
Nowaday, it is known that both embryo and adult contain NSCs. Mammalian NSCs produce 
different cell types at different developmental stages. Three models have been proposed for the 
origins of cells in the CNS (Wen et al., 2009). According to the first model, NSCs might 
generate two progenitor groups: neural restricted progenitors (NRPs) and glial restricted 
progenitors (GRPs). Then these two groups give origin to neuronal and glial cell types, 
respectively. Another theory predicts that neurons and glial cells arise from the same progenitors 
located in different areas of the nervous system. The last model suggests that in the motor neuron 
progenitor (pMN) domain NSCs might sequentially differentiate into olig-positive motor 
neurons, oligodendrocyte and olig-negative astrocyte precursors. A temporal regulated activation 
of specific genes may coordinate these events. The mechanisms of mammalian NSC 
commitment are largely unknown and might involved extrinsic and intrinsic mechanisms, such 
as changes of signal environment, transcription factor expression patterns and epigenetic 
modifications. 
In Zebrafish neurogenesis shows several similarities with that of mice and chicken. Once more, 
the external embryonic development makes Zebrafish nervous system accessible for any kind of 
experimental manipulation. Notably, it has a greater neurogenic ability and this has made it an 
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interesting vertebrate model for neurogenesis. 
As seen in other species (fruit fly, Xenopus, chicken, mouse), a complex network of chemical 
signals is implicated in each step of the nervous system formation.  
Following some of these pathways are presented.   
 
BMP signalling 
In addition to promoting bone formation, BMPs, especially BMP2 and BMP4, exhibit diverse 
activities in brain development (Wen et al., 2009). They act at different stages of neural 
development and in different regions of the CNS to regulate proliferation and determine the cell 
fate and the manner of differentiation. BMP signalling also inhibits the transformation from 
primitive ectoderm into neural ectoderm and, once the neural tissue is established, BMP 
signalling promotes the regulation of dorsal neural cell type formation. Moreover, BMP 
signalling cross-talks with other developmental pathways, such as Wnt and Shh to coordinate 
cell proliferation and patterning allowing the formation of the appropriate numbers and types of 
differentiated neurons. In the developing neural tube, BMPs induce astrocyte specification rather 
than proliferation of pre-existing astrocyte precursors and inhibit oligodendrocyte specification 
(Wen et al., 2009). 
 
TGFb signalling 
In neural pathologies, the role of smad3/TGFb signal is not so clear. TGFb signalling disruption 
is correlated to several motor neuronal diseases, because of the neuroprotective and anti-
inflammatory effects of this pathway (Katsuno et al., 2011). Its over-activation is associated to 
the formation of β-amyloid plaques in Alzheimer's disease (Town et al., 2008). Studies regarding 
axons development report that TGFb-like neurotrophic factors, such as GDNF and nodal, have 
neurotrophic effects on dopaminergic neurons. Notably, GDNF is able to induce axon-
regeneration (Ho et al., 2000). It seems to be involved in glia differentiation and extracellular 
matrix (ECM) components production to constitute a scaffold for neuron localization in the 
neural tube, but also as a source of neurotrophic factors that stimulate neurogenesis and axon 
growth (Gomes et al., 2005). 
 
Shh signalling 
Shh is able to promote proliferation of both neural and non-neural tissues. It stimulates neural 
stem cell proliferation by regulating the expression of N-Myc, cyclin D1, E2f1 and E2f2 (Wen et 
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al., 2009). In addition to the roles in proliferation and differentiation, Shh signalling seems to 
control cell death, because some of its downstream genes such as N-Myc and cyclin D1 are 
involved in the regulation of cell survival. Shh pathway has been involved in the specification 
and development of oligodendrocytes (Wen et al., 2009). Alterations of Shh signalling are 
closely associated with neuroectodermal tumor formation. 
 
Wnt signalling 
Wnt signalling is implicated in the control of cell growth and differentiation during CNS 
development. Many studies show that this signalling induces neuronal and astroglial 
differentiation, but suppresses oligodendroglial differentiation (Wen et al., 2009). In early 
embryonic development, Wnt signalling promotes proliferation of early neural progenitor cells 
(NPCs), whilst it stimulates neural differentiation on late NPCs. 
 
Notch signalling 
In the nervous system, Notch signals stimulate the expression of HES (hairy and enhancer of 
split paralogues) genes, like Hes1 and Hes5, and the HES-related genes Hesr1 and Hesr2 which 
belong to basic helix-loop-helix (bHLH) transcriptional repressor. Both N-Myc and c-Myc are 
targeted by Notch, which play several roles in regulating cell cycle (Wen et al., 2009). These 
evidences show the importance of Notch signalling in the developmental processes such as stem 
cell self-renewal, cell fate determination and differentiation. Notably, during mammalian CNS 
development, Notch signalling maintains neuronal progenitor renewal, inhibits neuronal 
commitment, promotes astrocyte formation, prevents oligodendrocyte formation. 
 
 
4. Pancreas development in Zebrafish 
The pancreas is both an endocrine and exocrine organ: it controls the blood glucose level and 
secretes some digestive enzymes. The endocrine pancreas synthesizes glucagon (alpha-cells), 
insulin (beta-cells), somatostatin (delta-cells), pancreatic polypeptide (PP-cells) and ghrelin 
(epsilon-cells) (Pauls et al., 2007) (Prado et al., 2004) (Wierup et al., 2004). The exocrine 
pancreas consists of exocrine glands called acini that produces digestive enzymes such as trypsin 
amylase and carboxypeptidase A and a branched network of ducts that guides them to the gut 
(Fig. 6).  
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Fig. 6. Pancreas morphology. The pancreas is both an endocrine and exocrine organ. It produces 
digestive enzymes, that are secreted by the acinar cells into the gut via the pancreatic duct. The endocrine 
pancreatic cells include: alpha, beta, delta, PP cells and (not shown) epsilon-cells. These cells produce 
glucagon, insulin, somatostatin, pancreatic polipeptide and grelin, respectively (Edlund, 2002). 
 
The mammalian pancreas emerges from the duodenum as a ventral and a dorsal bud that 
eventually fuse to form the organ (Slack, 1995). Both buds contain precursors for all pancreatic 
cell types, but they give rise to different parts of the pancreas. The human pancreas can be 
subdivided in a head and a tail region referring to the proximal and the distal part of the organ. 
Precursors of the ventral bud give rise to the posterior part of the head, whilst the dorsal bud 
contains precursors for the anterior part of the head and the tail.  
The transcription factors involved in the pancreas formation can be divided in two groups 
(Edlund, 2002) (Jensen, 2004; Schwitzgebel, 2001) (Wilson et al., 2003). A group is represented 
by those factors expressed in the pancreatic anlage and necessary for both endocrine and 
exocrine part developments. Pdx1, Ptf1a and Mnx1 belong to this category. The other group of 
transcription factors is involved in the differentiation of pancreatic endocrine cell types. Some of 
them are NeuroD, Pax6, Pax4 and Nkx2.2 (Jensen, 2004) (Wilson et al., 2003).  
In Zebrafish, pancreas develops from two buds: one placed dorsally to the gut, the other one 
located ventrally and anterior to the first. The posterior dorsal bud is formed by two cell 
populations that converge at the midline of the forth somite between 14 and 18 somite stages to 
form a single pancreatic bud (Field et al., 2003). The anterior ventral bud develops near the liver 
and emerges at 40 hpf. It seems to give rise to pancreatic duct and exocrine tissue, whilst the 
posterior bud forms the islet. At 44 hpf the two buds keep contact and at 52 hpf they are 
completely fused (Field et al., 2003).  
Many of the transcription factors discovered in mammals are also expressed in the zebrafish 
pancreas. Transcription factors such as pdx1, nkx2.2a and pax6b are expressed in the endoderm 
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shortly before or in parallel to the onset of insulin expression at 12 somites (Biemar et al., 2001). 
Insulin expression is followed by somatostatin at 16 somites and glucagon at the end of 
somitogenesis (24 hpf) (Argenton et al., 1999) (Biemar et al., 2001). The mRNAs for the first 
digestive enzymes are detectable at 48 hpf (Biemar et al., 2001) (Yee et al., 2005). The entire 
exocrine pancreas and late differentiating endocrine cells are generated from ptf1a-positive 
precursors situated in the so-called anterior pancreatic bud (Field et al., 2003) (Lin et al., 2004), 
(Yee et al., 2005), (Zecchin et al., 2004). For Zebrafish nkx2.2 two homologues have been 
identified. Nkx2.2a a is expressed in the ventral CNS and in the pancreas (Barth and Wilson, 
1995) and (Biemar et al., 2001). Nkx2.2b is also expressed in the central nervous system but was 
not detected in the endoderm (Schafer et al., 2005). At the 10 somite stage nkx2.2a is first 
detectable in the pancreatic primordium and thereafter in the mature pancreatic duct (Pauls et al., 
2007).  
The expression of these transcription factors is ruled by chemical signals emanating from the 
surrounding tissues. For instance, Shh and Ihh are absent in the foregut region, which will give 
origin the posterior bud. Ectopic expression of Shh in the developing pancreatic endoderm of 
mice and chicken abolishes Pdx1 expression. On the other hand, Shh signalling inhibition 
produces extra pancreatic buds and an increase of pancreas size and beta-cell number (Tehrani 
and Lin, 2011). Blocking Shh in early development leads to a sever reduction of endocrine cells 
in Zebrafish, too (diIorio et al., 2002). Nevertheless, the same signalling seems to play a different 
role after gastrulation. In fact, a later Shh inhibition causes an ectopic expression of beta-cells 
(diIorio et al., 2002). It has been proposed a dual role for this pathway: at early gastrulation it 
promotes migration and differentiation of pancreas progenitors (both exocrine and endocrine 
cells). By late gatrulation, it switch to a negative role antagonizing retinoic acid and, therefore, 
inhibiting endocrine pancreas specification, but still stimulating exocrine (Tehrani and Lin, 
2011). 
BMP is another important signalling for pancreas formation. It promotes the hepatic fate at the 
expense of the pancreatic one (Zahra Tehrani and Shuo Lin, 2011). It also promotes the budding 
of the anterior ventral bud, whilst it inhibits beta-cells induction (Chung et al., 2009).  
Wnt signalling has been suggested to exert a role during early and late stages of gastrointestinal 
development. In mouse, Wnt4 expression was observed in the late pro-endocrine cells and 
differentiated endocrine cells as well as the intestinal and stomach epithelia. At later stages of 
development, Wnt4 expression became restricted to the islets with preferential high expression in 
non–β-cells. Wnt7b expression was also expressed in the pancreatic epithelium at later stages. 
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Frz3 is expressed in the early pancreatic buds, but appears reduced at later stages. These data 
suggest a role for Wnt signalling in the pancreatic epithelium proliferation during the major 
phase of pancreatic growth (Papadopoulou and Edlund, 2005). Furthermore, some 
polymorphisms of the transcription factor TCF7L2 impair glucose-stimulated insulin secretion in 
humans, suggesting that perturbations in the Wnt signalling may contribute to the pathogenesis 
of type 2 diabetes (Liu and Habener, 2010). 
 
 
5. Angiogenesis and BMP 
During embryonic development, formation of vasculature system consists of two sequential 
steps: vasculogenesis and angiogenesis. de novo development of blood vessels (vasculogenesis) 
is followed by remodelling and growth of new vessels from the pre-existing ones (angiogenesis) 
(Moser and Patterson, 2005).        
In vivo and in vitro experiments have demonstrated the importance of BMP pathway in both 
processes. For example, (Boyd et al., 2007) and bmp2 overexpression leads to neoangiogenesis 
in tumor mass (Langenfeld and Langenfeld, 2004). The inhibition of BMP signal impairs 
gastrulation and vascular differentiation in mice (Moser and Patterson, 2005). Conditional 
knockout of the mouse BMP type 1a receptor (ALK3) after initial embryonic patterning decrease 
the vessel formation and alters the recruitment of smooth muscle cells to the vasculature (Park et 
al., 2006). 
It has been also demonstrated that in Xenopus the removal of dorsal aorta blocks endocrine cell 
differentiation (Lammert et al., 2001). Furthermore, in the absence of this vessel the murine 
prepancreatic endoderm fails to express the endocrine marker ins (Lammert et al., 2001). On the 
other hand, Field et al. have demonstrated that both endocrine and exocrine pancreas develop 
normally in Zebrafish lacking most endothelial cells. The authors have tried to explain this 
difference envisaging the presence of other tissues that might provide inducing signalling for the 
pancreas. 
 
 
 
6. Aim of the study 
In this thesis I will show how the reporter lines produced in our lab can be used for in vivo study 
of the morphogenetic signalling pathways: BMP, TGFb, Wnt and Shh. 
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As first, I will explain how these transgenics have been validated through chemical treatment and 
microscope observation and latter focusing my attention on smad3/TGFb reporter line, not yet 
characterized and published. Molecular and genetic approaches have completed the analysis of 
the smad3-responsive line.  
These analyses were needed to demonstrate that each reporter is faithfully responsive to the 
corresponding chemical signal and, therefore, the data obtained through them are perfectly 
reliable. 
  
Then, I will present two different projects that take advantage of the use of Zebrafish transgenic 
lines: 
- smad3 and neurogenesis: the role of smad3-mediated TGFb during the nervous system 
development is not well cleared. Since this signalling is impaired in cancer (Schiavone Marco et 
al., 2014) as well as in many pathologies with an altered inflammatory process (Lan, 2011) 
(Fiocchi, 2001) (Anthoni et al., 2007), it is important to understand how this signalling work in 
physiological conditions 
- morphogens epistasis. The interactions among chemical signals are very important to direct the 
cell proliferation, differentiation and movement during embryogenesis. This network is impaired 
in many pathologies. Our study wants to offer a new approach for evaluating in vivo these 
mechanisms, both in physiological and pathological conditions. 
 
As further example of the use of these reporter lines, it will be illustrated a preliminary study 
regarding the pancreas development and the role of morphogens in early larval development. 
Many studies have been done on the relation between each morphogen and pancreas. 
Nevertheless, most of them analyse these pathways in early embryonic development (till 
gastrulation and/or early somitogenesis). Less is known about the role of these pathways during 
organogenesis (after 24 hpf). For this reason, the four reporter lines have been crossed to other 
transgenics with a pancreas-specific expression and observed in vivo during the first month of 
development at the confocal microscope. I will conclude this analysis with a functional study to 
understand the role of BMP in pancreatic angiogenesis 
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MATERIALS AND METHODS 
 
 
Animals 
Zebrafish (Danio renio) is a tropical fish, native to the Himalayan region, belonging to the 
minnow family (Cyprinidae) of order Cypriniformes.  
Animals were staged and fed according to methods and rules described by Kimmel C.B. et al. 
(Kimmel et al., 1995). The project was examined and approved by the Ethics Committee of the 
University of Padua with protocol number 18746. Fish are maintained in large scale acquaria 
systems (Aquarienbau Schwarz, ZebTech, TECNIPLAST and Mueller-Pflegger)Reciricluation 
systems with biological filters and a reverse osmosis supply  guarantee the high-quality water 
and a regular water exchange rate. These systems allow to raise and maintain a large amount of 
fishes. Water is sterilized by UV radiation before distribution to the tanks in order to reduce the 
risk of diseases spread. 
Fish are kept in overflow tanks with different volume depending on the number of the 
individuals: 1 liter tank for single animal, 5-10 liters containers for 2 up to 30 fish.  
pH, temperature and saline conditions are maintained constant: pH of about 7, temperature of 
28.5°C and conducibility between 200 and 400 µS. Timers regulate the dark/light cycle (12 
hours light, 12 hours dark). 
Animals are fed once with dry food (TetraMin) and twice with living Artemia salina nauplia. 
Artemia is a species of small shrimps. It is bought as cysts and then raised to nauplia stage into 
some hatcheries. These hatcheries consist of inverted cones lighted with a neo lamp. 80 ml of 
cysts are dispersed into 8 liters of water containing 192 g of NaCl. A porous stone inflates air 
and mix Artemia keeping them alive. After two days, they are completely hatched and nauplia 
can be harvested. Aeration is stopped to separate the nauplia (on the bottom) from the cyst shells 
(floating on the water). Then, nauplia are filtered to remove not-hatched cysts and the excess of 
salt. The nauplia are resuspended in fresh water and distributed to the fish. 
Zebrafish are mated on late afternoon using suitable mating boxes (Westerfield, 1995) These 
boxes consist of a plastic tank with an internal removable container with a grid on the bottom. 
This grid avoids fishes to eat eggs. Sometimes a small bundle can separate fish pair till the 
mating to reduce fish aggression. Fishes mate on the morning when the light turns on. Eggs are 
harvested with a tea net and transferred in Petri dishes containing embryo medium (fish water). 
Eggs are then controlled at the dissection microscope to separate living embryos from 
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unfertilized eggs and dead embryos. Embryos are incubated at temperature between 25 and 33°C 
and then can be either fixed for immunohystochemistry or mRNA in situ hybridization (ISH) or 
raised to the adulthood. 5 dpf larvae are transferred in 1 liter tanks and maintained in an 
incubator at 28.5°C until they reach two weeks, when they are moved to the ZebTech, 
TECHNIPLAST acquaria. Zebrafish larvae are fed twice with dry Artemia powder (Novotom, 
JBL) from 5 dpf.     
We used wild-type (wt) UMBRIA and Giotto-Leo Zebrafish (Danio renio) strains in all the 
experiments.  
 
Screening of oepm134 and dintt250 lines 
 
Oneeyedpinhead (oepm134) (Schier et al., 1996) and chordin (dintt250) (Schulte-Merker et al., 
1997) mutant carriers have been identified both by PCR analysis and phenotypes screening of 
their offspring at 24 hpf.  
 
Tail fin clipping 
1. Fill small fish tanks with system water 
2. Fill a 50 ml becker with 48 ml system water and 2 ml of 25x tricaine 
3. Move a fish into the tricaine solution and wait for the fish to stop moving 
4. Take the fish with a spoon and put it on a clean glass Petri dish 
5. Cut 1/3 of the tail with surgical scissors 
6. Place the fish into the previously prepared tank and label with the same number both the fish 
and the corresponding tail sample 
 
Genomic DNA extraction  
1. Put the tail sample in 100 µl of lysis buffer (10 mM tris pH 8.2: 10 mM EDTA; 200 mM 
NaCl; 0.5 % SDS) 
2. Vortex for 30 seconds 
3. Add 10 µl of Proteinase K (10 mg/ml) and incubate O/N at 55°C. Stop the reaction incubating 
at 98°C for 10 minutes 
4. Store the lysate at -20°C 
5. For PCR dilute the sample with nuclease-free water (1:20) and use 2.5 µl of this dilution 
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Genotyping of oepm134 and dintt250 lines 
For oep PCR screening, the following primers have been used: oepm134-wtFw (5'-
GGCTCCCTCAGAACACTGTC-3'), oepm134-mutRv (5'-GGCTCCCTCAGAACACTGTA-3') 
and oepm134-Rv (5'-CTCTTGGGCACAAAAGAGAA-3'). The annealing temperature is: 58°C. 
For dino PCR screening, the following oligonucleotides have been used: dino-Fw (5'-
GACACAAATGCGGGGTAAAC-3'), dino-Rv (5'-ATGTTGCAACTCAGCAGCAG-3'), dino-
wtRv (5'- CTGTGCACAACTCAC-3') and dino-mutRv (5'- ACTGTGCACAACTCAC-3').  
The annealing temperature is: 52°C. 
 
Zebrafish transgenic lines 
For functional in vivo studies we have used the following transgenic lines: tg(Ngn1:GFP)sb1, 
tg(gfap:GFP)mi2001, tg(mnx1:GFP)ml2 and tg(Nkx2.2a:mGFP)vu17. For NeuroD, we used a 
transgenic line, tg(-2.4kb neurod:EGFP), previously produced in our Lab.  
For smad7 overexpression, we used tg(hsp70:smad7/YFP) line, gift of Prof Dirk Meyer. 
For pancreas studies the following transgenic lines have been mated: tg(nkx2.2a:mEGFP)vu17, 
tg(-1.2ins:HSV.UL23-GFP)ia8), tg(ins:dsRED)m1018, tg(gcga:GFP)ia1, tg(−5.5Ptf1a:DsRed)ia6, 
tg(Ptf1a:GFP) and tg(kdrl:GFP)la116. 
For all the in vivo studies, the following reporter lines have been created in our lab: 
- smad3/TGFb: tg(12xSBE:EGFP)ia16 and tg(12xSBE:nls-mCherry)ia15 lines 
- BMP: tg(BMPRE:EGFP)ia18 and tg(BMPRE:nls-mCherry)ia17 lines 
- Shh: tg(12xGli-Hsv.Tk:GFP)ia11 and tg(12xGli-Hsv.Tk:nls-mCherry)ia10 lines 
- beta-catenin/Wnt: tg(7xTCF-Xla.Siam:GFP)ia4 and tg(7xTCF-Xla.Siam:nls-mCherry)ia5 lines 
- Notch: tg(Tp1bglob:eGFP) and tg(Tp1bglob:nls-mCherry) lines  
 
Generation of tg(12xSBE:EGFP)ia16 and tg(12xSBE:nls-mCherry)ia15 lines 
12 repeats of a smad3-binding sequence, so called CAGA box (Dennler et al., 1998), have been 
amplified together with major late promoter Adenovirus (MLP) with the attB4cagafor (5'-
GGGGACAACTTTGTATAGAAAAGTTGGCCCGGGCTCGAGAGCCAG-3') and 
attB1cagarev (5'-
GGGGACTGCTTTTTTGTACAAACTTGTTGGAAGAGAGTGAGGACGAA-3') 
oligonucleotides and then cloned into a pDONORTM P4-P1R according to the manifacturer's 
guideline (Invitrogen Multisite Gateway System, CA). The resulting Gateway 5’ entry vector has 
been recombined with a middle entry vector containing a reporter gene (EGFP, nls-mCherry, 
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CFP), pME vector, and a 3'entry vector containing SV40 poly A sequence. 25-50 pg of the 
obtained Tol2 vector containing smad3-responsive sequences has been co-injected together with 
25 pg of in vitro synthesized Tol2 Transposase mRNA into one-cell stage wild-type embryos. 
Mosaic transgenic fishes have been selected at roughly 24 hour post-fertilization (hpf) for 
fluorescent expression and grown up to the adult stage for screening. Positive founders have 
been selected for the fluorescence level of their offspring in areas of known Smad3 activity and 
by checking responsiveness of reporter expression to SB-431542 (S4317, Sigma, MO), a known 
Alk4- Alk5-inhibitor (Fig. S3). A founder for EGFP, nls-mCherry and CFP reporter lines has 
been selected and used to follow in vivo smad3-mediated TGF-beta signalling. 
 
Chemical treatments 
The following drugs were used to modify chemical signals: 
- SB431542 (S4317, Sigma, MO): Alk4 and 5 inhibitor; stock solution 100 mM; final 
concentration 100 µM 
- LY364947 (L6293, Sigma, MO): Alk5-inhibitor; stock solution 6 mM; final concentration 40 
µM. For treatment at 2 hpf, a final concentration of 10 µM in zebrafish fish water has been 
utilised 
- LDN193189 (SML0559, Sigma, MO) Alk2 and 3 antagonist; stock solution 10 mM; final 
concentration 10 µM 
- Dorsomorphine (S7306, Selleckchem, TX) inhibitor of Alk2, 3 and 6 and AMP-activated 
protein kinase (AMPK); stock solution 10 mM; final concentration 20 µM 
- DAPT (D5942, Sigma, MO): gamma-secretase inhibitor; stock solution 100 mM; final 
concentration 100 µM 
- SU5402 (SML0443, Sigma, MO): FGFR antagonist; stock solution 10 mM; final concentration 
10 µM 
- Purmorphamine (S3042, Selleckchem, TX): Smoothened agonist; stock solution 100 mM; final 
concentration 60 µM 
- Cyclopamine (S1146, Selleckchem, TX): Smoothened antagonist; stock solution 100 mM; final 
concentration 100 µM 
- BIO (13123, Cayman CHEMICAL, MI): inhibitor of glycogen synthase kinase-3β (GSK-3β); 
stock solution 5 mM; final concentration 5 µM 
- IWR-1 (I0161 Sigma, MO):  agonist of glycogen synthase kinase-3β (GSK-3β); stock solution 
20 mM; final concentration 10 µM 
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All substances have been solubilised in pure DMSO, except for cyclopamine that has been 
solubilised in ethanol. The drugs have been diluted in zebrafish fish water containing 2 mM 1-
phenyl-2-thiourea (PTU) for treatment at 24 hpf. For treatment at 2 hpf no PTU was added. The 
chorion around the embryos is often not permeable to the drugs. Therefore, it has been manually 
removed with dissection needles before each treatment. 
Treatments have been done in 6 or 24 well-plates. Embryos and larvae have been fixed in 4% 
paraformaldehyde (PFA)/PBS overnight at 4°C and then stored in pure methanol at - 20°C.  
 
WISH: whole mount RNA in situ hybridization  
 
Whole mount RNA in situ hybridization has been performed as described before (Thisse et al., 
1993).  
Transformation of E.coli 
Vector containing EGFP sequence (pME:EGFP from Tol2 kit) have been introduced in bacterial 
E. coli cells (One Shot® TOP10 Chemical Competent E. coli, Invitrogen). Chemical competent 
bacteria have been thawed on ice. 10-50 ng of plasmid DNA have been added to the bacteria and 
left on ice for 30 minutes. Heat-shock has been performed at 42°C for 30 seconds and followed 
by incubation on ice for 2 minutes adding 200 µl of S.O.C. medium (Invitrogen™). The 
transformed bacteria have been incubated at 37°C on a shacker for 45 minutes. Then, cells can 
be plated on agar containing ampicillin for the antibiotic-resistance selection. After an O/N 
incubation positive colonies can be selected and cultured in Luria-Bertani medium with 
ampicillin. 
Purification of plasmid DNA 
Extraction and purification of plasmid DNA have been performed using a commercial kit 
provided by Qiagen (QIAprep Spin Miniprep kit). High-quality DNA plasmid has been eluted in 
100 µl of nuclease-free water. 
Anti-sense probe synthesis 
Plasmid has been linearized using ApaI restriction enzyme. Linearization reaction has been done 
in a total volume of 50 µl, using 1.2 µl of the restriction enzyme and the corresponding buffer 
and BSA: 
- plasmid DNA   5 µg 
- 10x Buffer    2 µl 
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- 100x BSA    0.5 µl 
- HindIII   1.2 µl 
- ddH2O up to 50 µl 
 
The reaction mix has been incubated at 37°C O/N. The linearized plasmid has been then purified 
using Phase Lock gel tubes (Eppendorf): 
- centrifuge column tube for 1 minute at max speed 
- add nuclase free water to 100 µl to the sample and transfer the volume in a Phase Lock column 
- add 50 µl phenol and 50 µl of chloroform 
- centrifuge for 5 minutes at mx speed 
- add 100 µl of chlorophorme and centrifuge at max speed for 5 minutes 
- transfer the aqueous phase containing the linearized plasmid in a new 1.5 ml tube  
- add 2.5 ml of absolute ethanol, 2 µl of glycogen and 0.2 M NaCl 
- mix well and precipitate O/N at -80°C 
- centrifuge 15 minutes at max speed 
- remove the surnatant and wash the pellet 3 times with 200 µl of 70% ethanol centrifuging 2 
minutes at max speed 
- remove the surnatant and dry the pellet  
- resuspend the pellet in 20 µl of nuclease-free water 
- run an electrophoresis on 1.55 agarose gel, loading 1 µl of the purified linearized plasmid 
 
Synthesis of RNA probe has been done in a 20 µl reaction volume at 37°C for 2 hours: 
- linearized plasmid       1µg 
- 10x transcription buffer (Roche)     2 µl 
- DIG-RNA Labelling Mix (Roche)     2 µl 
- RNAsin® Ribonuclease Inhibitor (Promega)   1 µl 
- T7 RNA Polymerase (Roche)     2 µl 
 
After the transcription, the template plasmid DNA is digested with 2 µl of DNAse (RNAse-free 
DNAse, Promega) at 37°C for 20 minutes. 
The purification of the anti-sense RNA probe has been performed using a commercial kit 
(MEGAclear™, Ambion®). The purified probe is stored at -80°C. To control and quantify the 
transcription, an electrophoresis has been performed on 1.5% agarose gel. Prior to be loaded on 
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gel, the probe has been denatured at 65°C for 5 minutes. 
 
WISH protocol 
Solutions: 
 
Hybridization mix (HM) 
60% formamide 
4.6 µM citric acid, pH 6 
5x SSC 
50 µg/ml heparin 
500 µg/ml torula yeast total RNA (tRNA) 
0.1% Tween-20 
dH20 up to 100 ml 
 
Washing mix 
HM without tRNA and heparin 
 
1x PBS 
150 mM NaCl 
10 mM Na2HPO4 
ddH2O up to volume 
 
1x PBT 
1x PBS  
0.1 % Tween-20 
 
PFA 
4% paraformaldehyde in 1x PBS 
 
Antibody anti digoxigenin 
The antibody used to recognize the digoxygenin was conjugated to alcaline phosphatase (AP) 
(Roche). It has been diluted 1:1000 in PBT/2% sheep serum/200 mg/ml BSA. 
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NBT/BCIP staining buffer 
100 mM Tris-HCl, pH 9.5 
50 mM MgCl2 
100 mM NaCl 
0.1% Tween-20 
ddH2O 
 
FAST RED staining buffer 
100 mM mM Tris-HCl, pH 8.2 
0.1% Tween-20 
 
FAST RED staining solution 
1 tablet of FAST RED (Roche) in 2 ml of the corresponding staining buffer. Filter the solution 
before to use it.  
 
Protocol 
- progressive rehydratation of the embryos (75%, 50%, 25% methanol in PBS): 5 minutes for 
each wash  
- 4 washes in PBT for 5 minutes 
- digest with Prtoteinase K (10 mg/ml): 7 minutes for 24 hpf embryos, 20 minutes for 48 hpf 
larvae. This step can be skipped for embryos younger than 24 hpf 
- briefly wash with PBT and then post-fix the digested embryos with 4% PFA for 20 minutes at 
RT 
- 4 washes PBT for 5 minutes 
- prehybridize the embryos in HM for 3 hours at 65°C 
- incubate at 63°C O/N with HM containing 100-200 ng/ml of the anti-sense probe 
- remove the probe and washes for 15 minutes with gradually decreasing solutions of HM 
(100%, 75%, 50%, 25%) in 1x SSCT pre-warmed at 65°C 
- wash twice with 2x SSCT at 65°C for 15 minutes 
- wash twice with 0.2x SSCT at RT for 15 minutes 
- wash for 15 minutes with gradually decreasing solutions of 0.2% SSCT (100%, 75%, 50%, 
25%) in 1x PBT 
- wash twice for 15 minutes at RT with PBT 
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- blocking with the blocking solution for at least 2 hours 
- incubate with anti-DIG antibody O/N at 4°C 
- wash 6 times at RT with PBT 
- wash 3 times for 15 minutes with the appropriate staining buffer 
- incubate embryos at RT in the dark in staining solution 
- monitor the reaction with the stereomicroscope and stop it with 4% PFA 
 
Morpholinos injections 
To generate a loss-of-function phenotype for a known zebrafish gene it is possible to transiently 
inhibit the protein function by injecting anti-sense oligos, namely morpholinos, into fertilized 
eggs (Nasevicius and Ekker, 2000). The morpholonos are 20-25 bases chemically modified 
oligos that bind specifically to the 5' UTR region or early coding sequence of a give mRNA and 
block the translation. Morpholinos can also be drawn to overlap splice site and to block splicing 
(Draper et al., 2001; Nasevicius and Ekker, 2000). Stability and, therefore, efficacy of a specific 
morpholino can be quite different, but they usually cannot block translation beyond 4 dpf. 
Smad2, 3a and 3b knock-down have been carried out injecting morpholinos previously tested by 
Jia S. et al. (Jia et al., 2008):  
 
MO-Smad2 5'-TTACCCTTCCTACGAAAAGCGTTCT-3' 
MO-Smad3a 5'-TTCAGTTCAGCGTTCCTTCCTCTATTGC-3'  
MO-Smad3b 5'-TTGTCCACGAGTCACATCACCGCAT-3' 
 
For Smad4, GeneTools, LLC, OR has synthesized 4 different morpholinos targeting this gene at 
either the start-codon or 3 different splicing sites:  
 
MO4(1) 5'- TCTCGCCCACCTGAACGTCCATCTC-3'  
MO4(2) 5'- TACTGATGTTGACGCTCTACCTCGC-3'  
MO4(3) 5'- GCAGTCTGAAAACAGAGAAGTCAGA-3'  
MO4(4) 5'- GTGTATGTGTTTCTCACCTTGATGT-3'  
 
Morpholinos were delivered as a sterile, salt-free lyophilized powder. The stock solution has 
been prepared adding nuclease-free water to have a final concentration of 8 mg/ml and then store 
at RT. 
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Morpholino working solutions have been prepared by diluting the stock solutions in 1x Danieau 
Buffer (58 mM NaCl; 0.7 mM KCl; 0.4 mM MgSO4; 0.6 mM Ca(NO3)2; 5 mM HEPES, pH 
7.6) with 0.5% Phenol Red (Sigma) to make the solution visible during the injection. 
 
All morpholinos for Smad4 have been injected at 1 mM concentration in tg(12xSBE:EGFP)ia16 
line. Effects on embryo morphology and EGFP expression have been observed at 24 hpf. 
MO4(3) has been adopted for in vivo experiments at lower concentration (0.5 mM). To verify its 
ability of control BMP signalling, it has been also tested in tg(BMPRE:EGFP)ia18 line.  
As control of each injection, we have injected a morpholino with the following scrambled 
sequence (MO-CTL) 5'-TTGTTGTTGTTGTTGTTGTTGTTGG-3' 
 
Before the injection, embryos have been collected and alligned along the border of a glass slide 
in the lid of a Petri dish. Injections have been performed under a dissecting microscope using a 
micromanipulator attached to a microinjector (Leica Microsystem). Both morpholino solutions 
and plasmid DNA dilutions have been loaded into the injection needles. The tip of the needle has 
been broken using a dissecting forceps. Embryos have been injected into the yolk sac at 1-2 cell 
stage and then incubated in 1x fish water at 28.5°C. 
 
Heat-shock induced overexpression of smad3b and smad7 
To validate tg(12xSBE:nls-mCherry)ia15 line, we have elicited overexpression of smad3b and 
smad7. For TGFb-associated transcription factor, we have injected 1-2 cell stage embryos of 
12xSBE line with a plasmid containing smad3b sequence in frame to YFP sequence under the 
control of heat-shock 70 promoter (hsp70). For TGFb general inhibitor smad7, tg(12xSBE:nls-
mCherry)ia15 line has been crossed to tg(hsp70:smad7/YFP) line. Heat-shock has been performed 
3 times at 37°C each 12 hours starting at 24 hpf. Larvae have been observed at confocal 
microscope 2 hours after the third heat-shock.  
 
Confocal analysis and colocalization measurements 
Fluorescence has been visualized at the Leica M165FC dissecting microscope and then at Nikon 
C2 H600L confocal microscope. For in vivo analyses embryos and larvae have been anesthetised 
with tricaine and mounted in 0.7% low melting agarose gel. EGFP and mCherry fluorescence 
have been visualized by using 488 and 561 nm lasers, respectively, through 20x and 40x 
immersion objectives (Nikon). All images have been analysed with Nikon software. 
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Colocalization has been measured with Volocity 6.0 software, whilst statistical analyses have 
been done with Prism GraphPad software. For analysis of smad3/TGFb evolution at 24 hpf, we 
have mated tg(12xSBE:nls-mCherry)ia15 to the following transgenics: tg(Ngn1:GFP)sb1, tg(-2.4kb 
neurod:EGFP), tg(gfap:GFP)mi2001, tg(mnx1:GFP)ml2 and tg(Nkx2.2a:mGFP)vu17. Confocal stacks 
of 6 tails at 24 hpf for each group of double transgenics have been recorded. Since 2 somites are 
formed each hour between 15 and 24 hpf, each tail has been divided in pairs of somites and a 
time-point value has been associated to each of them (hours of development). Colocalization has 
been expressed as Manders' coefficient referred to mCherry/TGFb and it has been measured in 4 
somites pairs. Resulting values have been plotted on a graph in function of the corresponding 
somite/time (hours of development). 
 
Fluorescence quantification 
GFP expression level has been measured through ImageJ software. Photos of 3 dpf treated larvae 
have been acquired with a Leica DMR microscope and saved as TIFF files. Each photo has been 
visualized as a color image (RGB). Therefore, it is splitted in the 3 colour components: green, 
red and blue. The green one has been used to quantify fluorescence level. A threshold has been 
set to highlight all the fluorescent areas in the picture and to decrease the auto-fluorescence of 
the embryo tissues. The same threshold is set for all the pictures. Fluorescence has been 
quantified and expressed as integrated density. Since some drugs (BIO and SU5402) cause an 
aspecific fluorescence effect, the integrated density has been measured for 3 not-fluorescent 
larvae treated with these drugs or DMSO. The mean value of these "aspecific fluorescence" has 
been subtracted to each integrated density value obtaining the real fluorescence value. For each 
group of treated larvae the mean value of "real" integrated density has been calculated together 
with the corresponding standard deviation using the GraphPad Prism Software. Data have been 
normalized respect to the integrated density of the control larvae.  
 
Whole-Mount Immunohistochemistry 
Embryos and larvae have been fixed in 4% PFA/PBS overnight and then stored in 0.15% 
TritonX-100 in PBS (PBTr) at 4°C.  
Protocol 
- tissues have been permeabilized through incubation with 10 µg Proteinase K at room 
temperature 
- 4 washes of 5 minutes in 1xPBS 
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- block with 4% BSA in PBTr for 2 hours at room temperature  
- specimens were immunostained with antibodies anti-phospho-smad3 (ab52903, Abcam, 
Cambridge, UK), anti-GFP (A10262, Lifetechnology, CA) and anti-phospho-histone H3 (06-
570, Millipore, MA), according to standard procedures: 4°C O/N on a shaker 
- 4 washes of 5 minutes in 1xPBS 
- block with 4% BSA in PBTr for 2 hours at room temperature  
- incubate in the dark at 4°C O/N with the following secondary antibodies: Goat Anti-Rabbit 
IgG, AP conjugate (Secondary Antibody Millipore™, 112448, Upstate™, MA), Alexa Fluor® 
488 Goat Anti-Chicken IgG (H+L) Antibody (A1-1039, Lifetechnology, CA) and Polyclonal 
Swine Anti-Rabbit Immunoglobulins/TRITC (R0156, DakoCytomation, Glostrup, Denmark) 
- 3 washes of 5 minutes with 1x PBS in the dark before to watch the results at the confocal 
microscope 
 
EdU proliferation assay  
Cell proliferation has been evaluated on embryos at 20 and 24 hpf.   
The Click-iT® EdU Alexa Fluor® 594 Imaging Kit (C10339, Life Technology).  In this assay 
the modified thymidine analogue EdU is efficiently incorporated into newly synthesized DNA 
and fluorescently labelled with a bright, photostable Alexa Fluor® dye. This fluorescent 
labelling of proliferating cells is accurate and compatible with immunohistochemistry.  
Protocol 
- chill 10 mM EdU solution on ice 
- move 10-20 embryos in a 2 ml eppy and remove fish water as much as possible 
- add 50 µl of 10 mM EdU solution and put the embryos immediately on ice 
- incubate on ice on a shaker (20 minutes for 24 hpf embryos, 10 minutes for 20 hpf embryos) to 
allow EdU uptake into the embryos (pulse) 
- 1 wash (1 minute) with cold fish water 
- 3 washes (5 minutes) with RT fish water to completely remove EdU  
- incubate embryos at 28.5°C for at least 30 minutes to permit the incorporation of EdU into the 
DNA of proliferating cells. The incubation time depends on the developmental stage and the 
tissues (chase) 
- fix embryos in 4% PFA and then dehydrate them with increasing concentration of methanol 
(25, 50, 75 and 100% methanol in PBS) 
- store in pure methanol at 20°C for at least 1 night 
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- rehydrate embryos with decreasing concentrations of methanol (75, 50 and 25% methanol in 
PBS) 
- 3 washes with 1xPBS 
- permeabilize embryos with 10 mg/ml proteinase K (20 minutes for 24 hpf embryos) 
- stop the reaction incubating with 4% PFA at RT 
- 3 washes with 1xPBS 
- incubate for 20 minutes with 1% DMSO in PBT (0.1% tween-20 in 1xPBS) 
- remove the DMSO solution and incubate O/N at RT in the dark with 50 µl of Click-iT™ 
reaction cocktail 
- remove the reaction cocktail and wash 3x for 10 minutes with PBT on a shaker 
- proceed with the microscope analysis 
- immunohistochemistry can follow this protocol 
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RESULTS 
 
 
1. Validation of reporter lines 
Our laboratory has developed a number of transgenic zebrafish lines expressing a reporter gene 
such as GFP, mCHERRY and CFP under the control of DNA elements responsive for specific 
cellular pathways involved in cell proliferation, stem cell maintenance and differentiation, tissue 
homeostasis and cancer (Wnt, BMP, TGFb, Shh). These responsive sequences have been found 
in literature and already validated in vitro.  
For Wnt signalling, tg(7xTCF-Xla.Siam:GFP)ia4 line has been obtained cloning seven repeats of 
TCF/LEF binding sites followed by the siamois minimal promoter (Maretto et al., 2003) (Moro 
et al.., 2012). 
For BMP pathway, two repeats isolated in the human Id1 gene has been cloned upstream to the 
Major Late promoter of Adenovirus to produce tg(BMPRE:EGFP)ia18 line (Lopez-Rovira et al., 
2002).  
For TGFb signalling, 12 repeats of smad3 specific sequence from the human PAI gene, namely 
CAGA box, have been cloned together with the major late promoter Adenovirus (MLP) to 
produce tg(12xSBE:EGFP)ia16 line (Dennler et al., 1998).  
For Shh tg(12xGli-Hsv.Tk:nlsmCherry)ia10 line contains 12 repeats of  Gli binding sites (from 
mouse hepatocyte nuclear factor-3beta or mHNF-3beta gene) together with the TK minimal 
promoter (Sasaki et al., 1997). 
To prepare these reporter lines, a Tol2 vector containing the sequences specific for each 
morphogen has been co-injected together with Tol2 Transposase mRNA into one-cell stage wild-
type embryos. Mosaic transgenic fishes have been selected at roughly 24 hour post-fertilization 
(hpf) and grown up to the adult stage for screening (Moro et al., 2013). Positive founders have 
been selected for the fluorescence level of their offspring in areas of known morphogen activity 
and by checking responsiveness of reporter expression to known specific inhibitor. Founders for 
EGFP, nls-mCherry and CFP lines have been positively selected and used to follow in vivo 
morphogens signalling.  
Before to use for our in vivo experiments, we have validated these transgenic lines in order to 
demonstrate their specificity. All of them have been treated with known specific drugs at 24 hpf: 
BIO and IWR1 for Wnt, LDN193189 for BMP, SB431542 for TGFb and cyclopamine for Shh. 
Fluorescence expression has been checked at epifluorescent microscope after two days of 
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treatment (Fig. 7a-b-c-d).  
For Wnt, BMP and TGFb we have evaluated the decrease of GFP mRNA through mRNA in situ 
hybridization (ISH). For this aim, 24 hpf embryos of these reporter lines have been treated with 
the appropriated inhibitor and fixed after 2, 4, 6 and 8 hours of treatment. GFP mRNA 
degradation shows a similar kinetic: within 8 hours the reporter transcript is completely 
eliminated (Fig. 7d, 8a and b). On the other hand, reporter protein is more stable than the 
corresponding transcript and, consequently, needs more time to be almost completely abolished.  
Since TGFb/smad3 reponsive line was the only unpublished line, we have performed a more 
detailed validation by chemical, genetic and molecular approaches on it.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7a. tg(BMPRE:EGFP)ia18 line: chemical validation. Brightfield and fluorescent images of 3 dpf 
larvae of tg(BMPRE:EGFP)ia18 from epifluorescent microscope,lateral views, left to right. Larvae have 
been treated with an Alk2 and 3 inhibitor. 
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Fig. 7b. tg(7xTCF-Xla.Siam:GFP)ia4 line: chemical validation. Brightfield and fluorescent images of 
3 dpf larvae of tg(7xTCF-Xla.Siam:GFP)ia4 line from epifluorescent microscope,lateral views, left to 
right. Larvae have been treated with a GSK-3 inhibitor (BIO) and a GSK-3 agonist (IWR-1). 
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Fig. 7c. tg(12xGli-Hsv.Tk:GFP)ia11 line: chemical validation. Brightfield and fluorescent images of 3 
dpf larvae of tg(12xGli-Hsv.Tk:GFP)ia11 line from epifluorescent microscope,lateral views, left to 
right. Larvae have been treated with a Smoothened agonist (purmorphamine) and a Smoothened 
antagonist (cyclopamane). 
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Fig. 7d. Chemical inhibition of TGFb signaling reduces reporter expression in 12xSBE lines. 
Brightfield and fluorescent images of 3 dpf larvae of Tg(12xSBE:EGFP)ia16, A-B', and 
tg(12xSBE:nlsmCherry)ia15, C-D', lines from epifluorescent microscope,lateral views, left to right. A-A', 
C-C', 3dpf larvae treated with DMO at 24 hpf and used as control; B-B', D-D', 3 dpf lavae treated with 
SB-431542 at 24 hpf. E, RNA in situ hybridization for EGFP mRNA performed on 24 hpf embryos of 
Tg(12xSBE:EGFP)ia16 treated with the Alk4- and Alk5-inhibitor, SB-431542, at 24 hpf and fixed at 
different time points: 2, 4, 6, 8 hours post treatment (hpt). 
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Fig. 8a. Chemical inhibition of BMP signalling reduces reporter expression in tg(BMPRE:EGFP)ia18 
line. Brightfield images of RNA in situ hybridization for EGFP mRNA performed on 24 hpf embryos of 
tg(BMPRE:EGFP)ia18 line treated with dorsomorphine, at 24 hpf and fixed at different time points: 2 (B), 
4 (C) and  6 (D) hours post treatment (hpt). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8b. Chemical inhibition of Wnt signalling reduces reporter expression in tg(7xTCF-
Xla.Siam:GFP)ia4 line. Brightfield images of RNA in situ hybridization for EGFP mRNA performed on 
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24 hpf embryos of tg(7xTCF-Xla.Siam:GFP)ia4 line treated with IWR-1, at 24 hpf and fixed at 
different time points: 2 (B), 4 (C),  6 (D) and 8 (E) hours post treatment (hpt). 
 
 
1.a Genetic and molecular validation of the tg(12xSBE:EGFP)ia16 and tg(12xSBE:nls-
mCherry)ia15 line 
To demonstrate that reporter expression correlates with smad3 activation, expression of 
phosphorylated smad3 has been checked by immunohistochemistry in 24 hpf embryos and 48 
hpf larvae (Fig. 9). At both stages, smad3 activation has been revealed in neural tube and tail 
mesoderm, with a decreasing rostro-caudal gradient, as seen in transgenic lines. Reporter-
expressing cells colocalize with smad3-activated cells (Fig. 9). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9. Phosphorylated-smad3 correlates to reporter expression in 12xSBE line. A, B, C, confocal 
lateral views of double fluorescent immunohistochemistry for GFP (green) and phosphorylated smad3 on 
embryo tail at 24 hpf; A'-A'', zoom images of the edge of the tail of a 24 hpf embryo; B-C', confocal 
images of double fluorescent immunohistochemistry for GFP (green) and phosphorylated smad3 on larva 
tail at 2 dpf; C, zoom view of the edge of the tail of a 2 dpf larva and, C',  the corresponding picture with 
the only red channel displayed.  
 
For the genetic validation of the 12xSBE lines the tg(12xSBE:EGFP)ia16 line has been crossed 
with one-eyed-pinhead (oep) and chordin (dino) mutant lines (Fig. 10). One-eyed-pinhead 
(TDGF1 or CFC1) is a cofactor of Nodal signalling, a subset of TGF-beta family, involved in 
mesendoderm specification, left-right axis specification and anterior-posterior axis orientation. 
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Maternal and early zygotic oep mRNA are ubiquitously expressed. During gastrulation, oep 
expression is confined in the gastrula margin. In the later stages, it is present in the forebrain, 
lateral plate and nothocord. In absence of zygotic oep, our TGF beta-responsive line lacks GFP 
expression in cardiac mesoderm, underlying the role of oep-mediated TGF-beta signalling in 
mesendoderm specification. On the other hand, the reporter expression is unchanged in the 
nervous system (Fig. 10B-B'''). In fact, it is known that Nodal signalling is dispensable for neural 
induction (Jia et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. smad3-induced EGFP expression is independent from smad1/5/8-BMP and partially 
dependent on nodal signalling. Brightfield and fluorescent lateral views of embryos at 24 hpf from 
epifluorescent microscope, left to right. A-A''', wild type (WT) 24 hpf embryo of tg(12xSBE:EGFP)ia16 
line. B-B''', oneyedpinhead (oep) mutant 24 hpf embryo of tg(12xSBE:EGFP)ia16 line. C-C''', chordin 
(chd) mutant 24 hpf embryo of tg(12xSBE:EGFP)ia16 line. A''', B''', C''', white arrow-heads indicate in 
each picture the cardiac mesoderm region. GFP expression is absent only in oep mutant. 
The effect of this mutant genetic background have also been evaluated in tg(BMPRE:EGFP)ia18 
line. No change of fluorescence expression is appreciable on oep mutant (Fig. 10).        
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Fig. 11. BMP-induced EGFP expression is independent from nodal signalling. Brightfield and 
fluorescent lateral views of embryos at 24 hpf from epifluorescent microscope, left to right. 
 
Chordin is a major Bmp2/4 antagonist, expressed in Zebrafish by shield stage. Both BMP and 
TGF-b belong to TGF-b superfamily and have a similar transduction pathway. However, they 
require specific receptors and receptor-activated smads. BMP and TGFb exert opposite role in 
neural induction (negative and positive effects, respectively). To evaluate the specificity of our 
transgenic line for TGFb-smad2/3, reporter expression has been evaluated in embryos missing 
the activity of chordin. Despite the obvious morphological changes due to axis specification 
disruption, we did not observe changes on fluorescence level in the nervous system of mutants 
(Fig. 10C-C'''). This seems to demonstrate an independent action of smad2/3-mediated signalling 
on neural induction (Jia et al., 2009). Furthermore, it is known that smad2/3 act on neural 
induction during gastrulation, at least in part, through chordin, but nodal signalling represent a 
subgroup of TGFb family. Nevertheless, other ligands, such as activin, can activate smad3 and, 
consequently, reporter expression.  
These transgenic lines have been created using elements recognized by smad3 transcription 
factor. To test their specific responsiveness, 1-2 cell-stage embryos of the 12xSBE lines have 
been injected with morpholinos for smad2/3a/3b/4 and their fluorescence has been checked at 24 
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hpf (Fig. 12 and S1). The morpholinos for smad2/3a/3b have been already tested and validated 
by Jia S. et al. (2008) and are able to induce different degree of neural degeneration and growth 
retardation; morphant embryos failed to form floor plate, had eyes malformation and bent 
nothocord (Jia et al., 2008) When injected in the 12xSBE lines, MO-smad2 was partially 
affecting the reporter activity in the neural tube. On the other hand, fluorescence was drastically 
reduced with MO-smad3b and completely abolished with MO-smad3a, evidencing a strong 
specificity of the 12xSBE transgenic lines for smad3 activity (Fig. 12 and S1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12. Different responsiveness of tg(12xSBE:EGFP)ia16 line to smad2, smad3a, smad3b and 
smad4 morpholinos. Brightfield and fluorescent lateral images of smad2-, smad3a-, smad3b- and 
smad4-morphants at 24 hpf at the epifluorescent microscope, left to right. smad2, 3a and 3b morphants 
show a similar phenotype: anterior truncation, a curved shortened body axis, absence of floorplate and an 
enlarged intermediate cell mass. smad4 morphants have a worst phenotype: similar characteristics of the 
other morphants accompanied to a shortened dorsalyzed body due to BMP inhibition. Reporter expression 
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is completely inhibited in smad4 and 3a morphants and strongly reduced in smad3b morphants. smad2 
morphants lack GFP expression in the cardiac mesoderm and telencephalon like the other morphants 
(white arrow head) and display a mild reduction in the neural tube. 
 
Both zebrafish smad3 isoforms, 3a and 3b, are expressed in the tail region (Pogoda and Meyer, 
2002) (Hsu et al., 2011) and the major efficacy of MO-smad3a might be due to either a higher 
activity of morpholino for smad3a or a higher expression/function of this gene. The higher 
reduction of mCherry transgene likely depends on intrinsic properties of this fluorescent 
molecule (Fig. S1). Whilst its fluorescence is as strong as EGFP, it needs more time to reach 
similar expression levels. Therefore, when smad-mediated transcription of mCherry is blocked, a 
longer time is needed to observe a level of mCherry compared with EGFP. In all smad3a, 
smad3b and smad2 morphants groups no fluorescence has been detected in the cardiac 
mesoderm. In fact these genes are known to play an important role in the mesoderm specification 
and outflow tract formation (Jia et al., 2008) (Zhou et al., 2011). Smad4 is a transcription factor, 
common to TGF-b and BMP signalling, that is necessary for the activation of the r-smad-
mediated signalling. For smad4, four morpholinos have been designed and tested for their ability 
to abolish GFP expression both in our TGF b-responsive. MO3-smad4, specific for a splicing-
donor site, was the most efficient in this effect and was used for injection (Fig. 13).  
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Fig. 13. Different responsiveness of tg(12xSBE:EGFP)ia16 line to the 4 morpholinos drawn for 
smad4. Brightfield and fluorescent lateral images of smad4 (I), smad4(II)-, smad4(III) and smad4(IV)-
morphants at 24 hpf at the epifluorescent microscope, left to right. All morphants show anterior 
truncation, a curved body axis and a dorsalyzed body due to BMP inhibition, but only MO-smad4(III) and 
MO-smad4(IV) morpholinos completely inhibit reporter expression. Furthermore, MO-smad4(III) and 
MO-smad4(IV) morpholinos cause a worst phenotype with more marked body defects.  
 
 
 
 
 
 
 
 
Fig. 14. smad4-knock-down inhibits GFP expression in tg(BMPRE:EGFP)ia18 embryos. Brightfield 
and fluorescent lateral images of smad4 (III) morphant at 24 hpf at the epifluorescent microscope, left to 
right. All morphants show anterior truncation, a curved body axis and a dorsalyzed body due to BMP 
inhibition. Morpholino completely blocks reporter expression. 
 
Smad4 morphants show the most severe growth retardation, eye malformation and nothocord 
defects when compared with smad2/3a/3b-morphants. 24 hpf smad4 morphant embryos are also 
dorsalized, as a consequence of BMP inhibition. As expected, smad4 morphants failed to 
activate the reporter (Fig. 11 and 12). Same result has been observed with the 
tg(BMPRE:EGFP)ia18 line (Fig. 14). This confirms both the specificity of our BMPRE line and 
the efficacy of the selected smad4 morpholino.                                                                                                     
To further demonstrate the specificity of our 12xSBE lines, we induced the overexpression of 
either smad7 or smad3b in 24hpf embryos (Fig. 15). Smad7 is an inhibitory smad able to block 
smad3-mediated TGFb signalling by inhibiting phosphorylation of type I receptor, recruiting 
smurf1 and 2 and leading to proteasomal degradation of ligand-receptor complex (Yan et al., 
2009). To induce an increase of smad7, the tg(12xSBE:nlsmCherry)ia15 line has been crossed 
with a transgenic line expressing the smad7-YFP  fusion coding sequence under the control of 
hsp70 regulatory region. Heat-shocked larvae analysed at the confocal microscope reveal a 
strong activation of YFP and a concomitant dramatic reduction of mCherry in the entire embryos 
(Fig. 15A-A'').                              
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Fig. 15. Tg(12xSBE:nls-mCherry)ia15 line is responsive to smad7 and smad3b overexpression. A-A'', 
confocal lateral images of 48 hpf double transgenic larvae, tg(12xSBE:nls-mCherry)ia15/hs-smad7/YFP. 
Heat-shock causes an overexpression of the reporter gene and an ubiquitous production of YFP. B-B'', 
confocal lateral images of 48 hpf not heat-shocked double transgenic larvae, tg(12xSBE:nls-
mCherry)ia15/hs-smad7/YFP and tg(12xSBE:nls-mCherry)ia15/hs-smad3b/YFP. Only not heat-shock 
tg(12xSBE:nls-mCherry)ia15/hs-smad7/YFP is shown as control. C-C'',  confocal lateral images of 48 hpf 
heat-shocked double transgenic larvae, tg(12xSBE:nls-mCherry)ia15/hs-smad3b/YFP. The heat-shock 
leads to a smad3b overexpression confirmed by mosaic production of YFP. An ectopic expression of the 
mCherry protein is the interesting effect of the heat shock, well visible in the muscles of the trunk, C'. 
White arrow heads show ectopic expression also in the head and tail, C,C''. Each picture shows mCherry 
fluorescence following the heat-shock and it is accompanied by a small figure representing merge of YFP 
(green) and mCherry (red) (upon, surrounded by white square).  
 
To stimulate an increase of smad3b expression, 1-2 cell stage embryos of the 
tg(12xSBE:nlsmCherry)ia15 line have been injected with a plasmid containing the smad3b-YFP 
fusion coding sequence under the control of hsp70 regulatory region. Embryos at 24 hpf stage 
have been heat-shocked three times every 12 hours at 30°C for 30 min and analysed by confocal 
microscopy. As shown in the picture, only heat-shocked embryos show expression of the YFP. 
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Due to the fact that a plasmid has been injected, the expression is mosaic. Notably, 12xSBE 
reporter expression levels are significantly increased and accompanied by an ectopic activity  
(i.e., muscle in the trunk) meaning that smad3 driven by hsp70 promoter is able by itself to 
activate the reporter (Fig. 15C-C'').                                                                                                                             
In conclusion, pharmacological, mutants, morpholinos and molecular analyses show that the 
zebrafish 12xSBE lines are bona fide TGFb/smad3 responsive, in vivo. 
 
2. Fluorescence expression pattern in Wnt, BMP and Shh reporter lines  
For all reporter lines, fluorescence expression has been observed from 1 to 4 dpf at the 
epifluorescent and confocal microscopes.  
In the 7xTCF-Xla.Siam lines, reporter expression is active during formation and maintenance of 
sensory organs, such as the lateral line, olfactory bulbs, taste buds, otic vescicles as well as in 
cardiovascular tissues, including heart valves and endothelial cells of the brain, liver and gills 
(Moro et al., 2012) (Fig. 16a).  
In the BMPRE lines the main reporter expression areas are vasculature and heart, muscle, 
maxillary and mandibular processes, pharyngeal arches, dorsal retina, otic vesicle, cloaca. 
(Fig.16b).  
For 12xGli lines reporter expression is restricted to the ventral side of the central nervous 
system, median musculature and craniofacial tissues (Fig. 16c).  
For both BMP and Shh reporter lines, fluorescence expression seems to be similar to that of 
similar reporter lines, produced with the same transcription factors-responsive sequences and 
already published (Laux et al., 2011) (Schwend et al., 2010). 
 
2.a Fluorescence expression pattern in TGFb/smad3 reporter line  
We then decided to analyze the spatio-temporal fluorecescent activity of 12xSBE lines. While a 
wide GFP expression is visible early after fertilization in the offspring of female 
Tg(12xSBE:EGFP)ia16 carriers, due to a maternal effect, a more specific and zygotic fluorescence 
appears at late somitogenesis (15 hpf) in the tail (both mesoderm and neural tube) and cardiac 
mesoderm region (Fig. 17). At 26 hpf fluorescence is also visible in telencephalic region. At 48 
hpf reporter expression gradually extends to the entire neural tube, maintaining a gradient 
decreasing from the tail (Fig. 17).  
Tg(12xSBE:EGFP)ia16 and tg(12xSBE:nlsmCherry)ia15 lines show a similar fluorescence 
expression pattern (Fig. S2). Differences have been seen in time expression due to the specific 
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intrinsic properties of each reporter gene.                                                                                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17. Fluorescence expression in early development of tg(12xSBE:EGFP)ia16 line. Brightfield and 
fluorescent lateral views of tg(12xSBE:EGFP)ia16 embryos at 15, 26 and 48 hpf, left to right. For each 
stage, it is reported mRNA in situ hybridization for GFP. A-A'', images of 15 hpf embryo of 
tg(12xSBE:EGFP)ia16 line. B-B'', pictures of 26 hpf embryo of tg(12xSBE:EGFP)ia16 line. C-C'', pictures 
of 48 hpf larva of tg(12xSBE:EGFP)ia16 line. GFP expression appears in late somitogenesis in the tail and 
cardiac mesoderm region. At 26 hpf GFP is also visible in the telencephalic region and clearly expressed 
in the embryo neural tube and tail mesoderm. At 48 hpf reporter expression is extended to the entire 
neural tube, maintaining a decreasing gradient from the tail and in some areas of the brain.  
 
A more detailed observation of the tg(12xSBE:EGFP)ia16 line at the confocal microscope gives a 
better understanding of cellular types activating TGFb signalling.  
In the anterior, the reporter is activated in the hindbrain, diencephalon and telencephalon as 
evidenced in Fig. 19 and Vibe-Z analysis (Ronneberger et al., 2012).  
In the neural tube, fluorescent cells occupy ventricular and transition zones, where neuronal 
precursors proliferate and neuroblasts start their differentiation, respectively (Fig. 18E-F).  
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Fig. 18. Reporter expression during early larval development: central nervous system. Confocal 
images of brain and neural tube of tg(12xSBE:EGFP) larvae at different stage of development. A-A',D, 
error bar of 100 µm; B,C-C', E, error bar of 50 µm; B', C'', E'-F, error bar of 20 µm. A-A', dorsal view 
of the brain of a 4 dpf larva. GFP is expressed in the hindbrain, diencephalon and telencephalon. B-B', 
zoom lateral views of hindbrain in a larva at 3 dpf. GFP is expressed in radial glia. C-C'', magnified 
dorsal views of GFP-expressing cells in the telencephalic region of 10 dpf larva magnification of the 
hindbrain. D, zoomed dorsal view of a 15 dpf larva telencephalon. E, lateral view of the neural tube in a 
72 hpf larva and, E'-E'' lateral and sagittal magnified views of a 3d-reconstruction of the neural tube at 
the same stage. Reporter expression is mainly localized around the ventricular zone. F, zoomed lateral 
view of a 6 dpf larva neural tube. 
 
Outside of the central nervous system (CNS), fluorescence is distinguishable in the retina, lens 
and olfactory epithelium (Fig. 19D-E). Reporter-expressing cells are found in cardiac mesoderm 
at 24 hpf, where they give rise to the outflow tract (Zhou et al., 2011) (Fig. 20A-B'). In the heart 
region, the reporter is still expressed at 3-4 dpf in the outflow tract and some cells distributed in 
the dorsal aorta (Fig. 19C-C'). Few fluorescent cells are also distinguishable in the jaws at 4 dpf 
(Fig. 19F-F'), while a weak GFP expression is visible in pectoral fins and cloaca. These areas are 
even more appreciable in tg(12xSBE:nlsmCherry)ia15. In the tail and cardiac region, the reporter 
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expression is also found in mesoderm cells. In fact, smad3 signalling is known to be involved in 
mesoderm specification via Nodal signalling (Jia et al., 2008).  
At about one month post-fertilization, fluorescence decreases in the entire central nervous 
system, where it is still expressed at low level in ventral part of the neural tube, particularly in 
the telencephalic region. Notably, at this stage, some muscle fibers of the median musculature 
start expressing the reporter gene (Fig. 19H). In facts, the role of TGFb signalling in the control 
of muscle development is well-known (Ge et al., 2012) (Hsu et al., 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19. Confocal images of GFP-positive regions external to CNS during the first month of 
development. A-A', confocal lateral view of 26 hpf embryo. Reporter gene is activated in the cardiac 
mesoderm and around the outflow tract. Spared cells are also visible in the yolk ball. B-B', zoomed heart 
region of a 26 hpf embryo. C-C', ventral view of heart and dorsal aorta of a 4 dpf larva. GFP expression 
in this area is no longer visible beyond this stage. D, zoomed view of the eye of a 48 hpf larva. GFP-
positive cells are visible both in retina and lens. E, zoomed view of an olfactory pit of a 6 dpf larva; F-F', 
magnified image of jaw of 5 dfp larva. Few cells are visible in this area during the early larval 
development; G, lateral image of a 26 hpf embryo trunk. GFP expression is present in the neural tube 
with a decreasing gradient from the tail and cloaca. H, zoomed lateral view of the trunk region of a 40 dpf 
larva. Reporter expression is still present in the neural tube. Some fibers of the median musculature seem 
to activate smad3-mediated signalling during this developmental stage. 
 
In adult fishes, EGFP expression is localized along the spinal cord and into the lens, whilst in 
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tg(12xSBE:nlsmCherry)ia15 fluorescence is detectable in ventricular zone of brain and 
telencephalic region (Fig. 20). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20. Images of reporter expression in adult fishes of 12xSBE lines. . Brightfield and fluorescent 
views of tg(12xSBE:EGFP)ia16 and tg(12xSBE:nls-mCherry)ia17 adult fishes. Both reporter lines retain 
reporter expression, but in different districts: brain (telencephalon and ventricular zone) expresses the 
reporter gene in tg(12xSBE:nls-mCherry)ia17 (on the left), whilst tg(12xSBE:EGFP)ia16 expresses GFP 
along the spinal cord and in the lens (on the right).  
 
 
3. Smad3-mediated neurogenesis in Zebrafish1: in vivo study through a smad3-responsive 
transgenic line 
 
3.a TGFb/smad3 signalling is activated in glia and neuronal precursors  
Smad3 activation is known to have a neurotrophic effects on DOPAminergic neurons 
(Krieglstein et al., 2002) (Tapia-Gonzalez et al., 2011), motor neurons (Ho et al., 2000), 
interneurons (Garcia-Campmany and Marti, 2007) and also GFAP-expressing cells (Tapia-
Gonzalez et al., 2011). In these cell types, it seems to be involved in axons growth (motor 
neurons), differentiation process (interneurons), dislocation of differentiating neurons in the 
neural tube and radial glia differentiation (Stipursky and Gomes, 2007). 
Thus, supported by the pattern expression of 12xSBE lines, we focused our attention trying to 
understand the nature of cells in which the reporter is active. For this purpose, 
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tg(12xSBE:nlsmCherry)ia15 line has been crossed with some transgenic lines expressing GFP 
under the control of different promoters specific for neural progenitors (Ngn1), precursors 
(NeuroD and GFAP) and committed neural cells (Mnx1 and Nkx2.2a) (Fig. 21 and S31, S4 and 
S5).  
The reporter expression of each double transgenic has been followed during the first week of 
development at the confocal microscope. At a first glance, the higher colocalization has been 
seen with neuronal and glial precursor markers, GFAP and NeuroD. This was quantified in the 
tail region by using Volocity Software and representing it as Manders’coefficient referred as the 
percentage of mCherry (TGFb) intensity fluorescence colocalizing with GFP (neuronal and glial 
markers) (Fig. 21A''', B''', C''', D''' and E'''). For both these markers, the highest value has been 
obtained at 2 and 3 dpf.  
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Fig. 21. Reporter expression correlates to 
neuronal and glial differentiating cells. 
Confocal lateral view of tail of double 
transgenic larvae at 2, 3 and 4 dpf obtained 
mating tg(12xSBE:nls-mCherry)ia15 line with 
some transgenics expressing GFP in different 
neuronal and glial cells: tg(Ngn1:GFP)sb1, tg(-
2.4kb neurod:EGFP), tg(gfap:GFP)mi2001, 
tg(Mnx1:GFP)ml2 and tg(Nkx2.2a:mGFP)vu17. 
On the right, the last column reports graphs of 
colocalization measured in tail of each double 
transgenic larvae at 1, 2, 3 and 4 dpf. 
Colocalization has been expressed as Manders' 
coefficient referred to mCherry (percentage of 
mCherry fluorescence colocalizing with GFP) 
and has been calculated in six larvae. The 
average value has been reported on the graph 
for each time-point. A-A'', confocal lateral 
images of tails of double transgenic larvae 
tg(Ngn1:GFP)sb1 /tg(12xSBE:nls-mCherry)ia15 at 
2, 3 and 4 dpf with the corresponding 
colocalization graph. B-B'-B'', confocal lateral 
images of tails of double transgenic larvae tg(-
2.4kb neurod:EGFP)/tg(12xSBE:nls-
mCherry)ia15 at 2, 3 and 4 dpf with the 
corresponding colocalization graph. C-C'-C'', 
confocal lateral images of tails of double 
transgenic larvae 
tg(gfap:GFP)mi2001/tg(12xSBE:nls-mCherry)ia15 
at 2, 3 and 4 dpf with the corresponding 
colocalization graph. D-D'-D'', confocal lateral 
images of tails of double transgenic larvae 
tg(Mnx1:GFP)ml2/tg(12xSBE:nls-mCherry)ia15 at 
2, 3 and 4 dpf with the corresponding 
colocalization graph. E-E'-E'', confocal lateral 
images of tails of double transgenic larvae 
tg(Nkx2.2a:mGFP)vu17/tg(12xSBE:nls-
mCherry)ia15 at 2, 3 and 4 dpf with the 
corresponding colocalization graph. 
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To examine the evolution of cells activating TGFb signalling, measures of colocalization have 
been performed in the tail of 24 hpf double transgenic embryos with the following strategy. 
Between 15 and 24 hpf stages, somites are formed at a constant rate. Therefore, the tail region 
has been divided in pairs of somites and colocalization (expressed as Manders’coefficient 
referred to TGFb/mCherry fluorescence) has been evaluated in four regions starting from the 
edge of the tail toward the trunk (Fig. 22). The caudal somites are the youngest and the first that 
activate TGFb signalling in the neural tube. In our graphs, the colocalization of the first pair of 
somites correspond to the starting point of expression of TGFb signalling (0 hour) and has been 
plotted on graph in function of the somite/time of TGFb expression. As discernable from the 
graphs (Fig. 23), at the moment of its activation (time 0 hour) TGFb has its higher colocalization 
with Ngn1-expressing cells. Ngn1 is a typical marker of proliferating neural progenitors (Korzh 
et al., 1998). By moving toward the trunk, a reduction of TGFb signalling activation is visible in 
Ngn1+ cells, whilst it arises in NeuroD expressing cells (Fig. 22A''' and B'''). Notably, NeuroD is 
a marker of neuronal precursors (Korzh et al., 1998). In Mnx1-expressing cells (differentiating 
motor neurons), TGFb expression remains low in all four areas examined (Fig. 22D'''). GFAP is 
a gene associated in radial glia differentiation (Stipursky and Gomes, 2007). By observing results 
of TGFb colocalization with glial markers, TGFb/GFAP graph shows an evolution similar to that 
seen in TGFb/NeuroD graph, demonstrating an association of our signal with neuronal and glial 
precursors (Fig. 22C'''). A low percentage of mCherry expression has been seen in the Nkx2.2a-
expressing cells (mature oligodendrocytes and motor neuron precursors) (Fig. 22E''') (Gotoh et 
al., 2012).    
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Fig. 22. TGFb signalling appears in progenitor cells and is maintained in precursors. Confocal 
lateral view of tail of double transgenic embryos obtained crossing tg(12xSBE:nls-mCherry)ia15 to the 
following transgenics: tg(Ngn1:GFP)sb1, tg(-2.4kb neurod:EGFP), tg(gfap:GFP)mi2001, tg(Mnx1:GFP)ml2 
and tg(Nkx2.2a:mGFP)vu17. Colocalization measurement has been done in tail of 24 hpf double transgenic 
embryos with the following strategy. From 15 to 24 hpf, two somites are formed each hour. Therefore, 
tail region has been divided in pairs of somites and colocalization (Manders’coefficient referred to TGFb-
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mCherry fluorescence) has been evaluated in four of them (A', white dotted circles) starting from the edge 
of the tail toward the trunk, A'. For each time point, the average value of Manders' coefficient has been 
calculated from six double transgenic embryos and plotted on graph in function of the corresponding hour 
of development (hd), A''', B''', C''', D''' and E'''.  
 
3.b EdU assay shows that TGFb is a postmitotic signal 
Once established that TGFb signalling is mainly localized in committed neuronal and glial 
precursors, we wanted to understand the role of this signal in such kind of cells. Functional 
experiments with neuronal and glial transgenic lines show that smad3 activation is important for 
neuro- and gliogenesis. To check whether smad3 activation is involved in mitosis, we analysed 
how a cell proliferation marker, phospho hystone-3 (pH3), changes in MO-smad3a embryos at 
24 hpf and larvae treated with LY364947 at 48 hpf (Fig. 23A-D). Results show that reporter 
signal and pH3 immunofluorescence do not colocalize. Notably, blocking TGFb signalling leads 
to a significant increase of proliferating cells. To further confirm this, EdU proliferation assay 
has been performed on 20 hpf embryos, which have been treated with LY364947 at 12 hpf (Fig. 
23E-F'). Results show a strong increase of proliferation. Thus, at early stages of development 
TGFb signal seems to play an important role in regulating the cell cycle. Then, we verified the 
direct connection of TGF-beta signalling on neural progenitor cell cycle by EdU proliferation 
assay on tg(12xSBE:EGFP)ia16 embryos at 24 hpf (Fig. 23G-H'). Embryos treated with EdU have 
been fixed and stained after a chase of either 2 or 8 hours. Cells stained after a chase of 2 hours 
are roughly in S/G2 phase, while cells stained 8 hours after the EdU pulse are in G1 phase. 
Analysis of colocalization of GFP and EdU show that proliferating cells (2h chase) do not 
express the reporter, while postmitotic cells (8h chase) do it. In other words, at 24 hpf, the 
majority of cells with activated smad3 do not proliferate but have just undergone mitosis, letting 
us conclude that TGFb is a postmitotic signalling during central nervous system development.  
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Fig. 23. Smad3/TGFb signalling is active in post-mitotic cells. A-B',E-F',G,H, error bar of 100 µm; 
C'-C'', error bar of 50 µm; G',H', error bar of 20 µm. A-B', confocal lateral views of fluorescent 
immunohistochemistry for GFP (green) and phospho-hystone3 (red) on tg(12xSBE:EGFP)ia16 embryos 
injected at 1-2 cell stage either with the control, A-A', or smad3a-morpholino, B-B'. C-D, confocal lateral 
images of fluorescent immunohistochemistry for GFP (green) and phosphor-hystone3 (red) on 2 dpf larva 
of tg(12xSBE:EGFP)ia16 line treated with either DMSO (C-C'') or LY364947 (D). C'-C'', confocal 
zoomed views of hindbrain and tail of the fluorescent immunohistochemistry for GFP and phospho-
hystone3 on DMSO-treated larva of 12xSBE line. E-F', confocal lateral images of EdU assay on 20 hpf 
embryos treated with either DMSO (E-E') or LY364947 (F-F') at 12 hpf. G-H', confocal lateral images 
of pulse and chase EdU assay on 24 hpf embryos of tg(12xSBE:EGFP)ia16 line. Embryos have been fixed 
after a chase of either 2 (G-G') or 8 (H-H') hours (hrs) and stained for EdU (red) and GFP (green). EdU+ 
cells fixed after 2 h are roughly in S/G2 phase, while EdU+cells fixed after 8 h of chase are post-mitotic 
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cells. 
 
3.c In vivo blocking smad3-mediated TGFb signalling impairs neuronal and glial 
differentiation and increases the pool of progenitor cells  
To confirm the hypothesis that TGFb signalling blocks proliferation of some progenitor cells 
allowing their differentiation, smad3a and smad3b morpholinos have been injected in 1-2 cell 
stage embryos of the transgenic lines, tg(Ngn1:GFP)sb1, tg(-2.4kb neurod:EGFP), 
tg(gfap:GFP)mi2001, tg(Mnx1:GFP)ml2 and tg(Nkx2.2a:mGFP)vu17 (Fig. 24). At 24 hpf both 
smad3a and smad3b morphant embryos show a decrease of GFP expression in motor neurons 
(hlbx9), with defects in axon development and soma position in the neural tube (Fig. 24D-D''). A 
similar decrease is also seen in oligodendrocytes in smad3a and b morphant embryos as revealed 
with GFP driven by the Nkx2.2a regulatory region (Fig. 24E-E''). The reduction of these cells in 
embryos treated with morpholinos against either smad3a or b is accompanied by a loss of their 
precursors as revealed by NeuroD and GFAP transgenics as well as an increase of neural 
progenitors revealed in Ngn1:GFP line (Fig. 24A-C'''). To complete the study of smad3 effect in 
functions in neural development, we have also co-injected smad3a and b morpholinos (data not 
shown). The results show that blocking both smad3 isoforms causes an aggravation of the 
embryo phenotype. However, the effects on the observed neural markers seem to be similar to 
those observe using each morpholino separetely. Therefore, smad3a and b seem to play both a 
necessary and additive genetic effect in the developing neural tube. 
Moreover, to further confirm the idea that TGFb signalling is a postmitotic signal able to stop 
progenitors proliferation and allow differentiation, a chemical approach has been followed by 
treating the same fish lines with the Alk5-inhibitor LY364947 either from 2 hpf to 24 hpf (Fig. 
24) or 24 hpf to 72 hpf (Fig. 25). As shown in Fig. 24 and 25, results of chemical treatments 
essentially recapitulate what already observed and reported with smad3 morpholinos: an increase 
of progenitors (Ngn1) together with a concomitant decrease of neuronal precursors and number 
of differentiated cells. In conclusion, both the chemical and genetic approaches have given same 
results on the role of TGFb in controlling the progenitor/precursor switch. 
To complete study of smad3 function, we have checked by immunohistochemistry markers 
linked to EMT (E-cadherin, cdh1, and N-cadherin, cdh2) in embryos and larvae analysed at 24 
hpf and at 48 hpf, respectively, and previously injected with MO-smad3a or treated with 
LY364947 (Fig. 26). Both chemical and genetic approaches used to block TGFb signalling led 
us to similar conclusions: while in physiological conditions smad3-responsive cells express N-
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cadherin, Smad3/TGFb inhibition reduces both reporter fluorescence and N-cadherin (Fig. 26A-
D') activating a concomitant increase of E-cadherin (Fig. 26E-H'). 
Therefore, we can say that the TGFb inhibition by blocking EMT determines a misplacement of 
mature neural cells such as motor neurons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 24. In vivo blocking of smad3/TGFb signalling impairs neuronal and glial differentiation 
during early embryonic development. Confocal Z-stack images of tail of 24 hpf transgenic embryos 
expressing GFP under control of either a glial or neuronal promoter: Ngn1, NeuroD, GFAP, Mnx1 and 
NKx2.2a. All these transgenic lines have been injected with morpholinos for smad3a and smad3b at 1-2 
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cell stage or treated at 2hpf with Alk5-inhibitor LY364947. Morpholinos and drug treatment give similar 
results: increase of proliferative cells (Ngn1), decrease of differentiating cells (NeuroD and GFAP) and 
reduction of late differentiating motor neurons and oligodendrocytes (Mnx1 and Nkx2.2a). Morpholinos 
and drug have been picked up, transgenics on the left. Ngn1 is tg(Ngn1:GFP)sb1. NeuroD is tg(-2.4kb 
neurod:EGFP). GFAP is tg(gfap:GFP)mi20001. Mnx1 is tg(Mnx1:GFP)ml2. Nkx2.2a is 
tg(Nkx2.2a:mGFP)vu17. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 25. In vivo blocking of smad3/TGFb signalling impairs neuronal and glial differentiation 
during early larval development. Confocal Z-stack images of trunk of 72 hpf transgenic embryos 
expressing GFP under control of either a glial or neuronal promoter: Ngn1, NeuroD, GFAP, Mnx1 and 
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NKx2.2a. All these transgenic lines have been treated at 24 hpf with Alk5-inhibitor LY364947 and 
confocal observation has been done after two days of treatment. Disturbing Smad3/TGFb signalling at 
early larval development causes an increase of proliferative cells (Ngn1), decrease of differentiating cells 
(NeuroD and GFAP) and reduction of late differentiating motor neurons and oligodendrocytes (Mnx1 and 
Nkx2.2a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 26. Smad3/TGFb signalling promotes EMT. A-D', confocal images of fluorescent 
immunohistochemistry  (IHC) for 12xSBE-associated GFP (green), N-cdh (red) and E-cdh (red) on the 
edge of the tail of control/smad3a 12xSBE morphants at 24 hpf and 12xSBE larvae treated with 
DMSO/LY364947 and fixed at 2dpf. A, IHC for GFP and N-cdh on control morphant tail of 
tg(12xSBE:EGFP)ia16 embryo and, A', the same area showing only IHC for N-cdh (red). B, IHC for GFP 
and N-cdh on tg(12xSBE:EGFP)ia16 larva (2 dpf) treated with DMSO and, B', the same area showing only 
IHC for N-cdh (red). C, IHC for GFP and N-cdh on smad3a morphant of tg(12xSBE:EGFP)ia16 embryo 
and, C', the same area showing only IHC for N-cdh (red). D, IHC for GFP and E-cdh on 
tg(12xSBE:EGFP)ia16 larva (2 dpf) treated with DMSO and, D', the same area showing only IHC for N-
cdh (red). E, IHC for GFP and E-cdh on control morphant tail of tg(12xSBE:EGFP)ia16 embryo and, E', 
the same area showing only IHC for E-cdh (red). F, IHC for GFP and E-cdh on tg(12xSBE:EGFP)ia16 
larva (2 dpf) treated with DMSO and, F', the same area showing only IHC for E-cdh (red). G, IHC for 
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GFP and E-cdh on smad3a morphant of tg(12xSBE:EGFP)ia16 embryo and, G', the same area showing 
only IHC for E-cdh (red). H, IHC for GFP and E-cdh on tg(12xSBE:EGFP)ia16 larva (2 dpf) treated with 
LY364947 and, H', the same area showing only IHC for E-cdh (red). 
 
 
4. Epistasis: how to study in vivo chemical signals interactions  
 
4.a  Chemical treatment: observation of fluorescence changes at the epifluorescent 
microscope  
The four reporter lines previously described have been used to study in vivo the interactions 
among the corresponding 4 morphogens, involved in various physiological and pathological 
processes. For this aim, each reporter has been treated with some drugs used to validate the 
others.   
Notch and FGF signalling pathways have been analysed together with these morphogens. 
Tg(Tp1bglob:eGFP) line and a γ-secretase inhibitor, DAPT, have been used to follow Notch 
pathway, while a vascular endothelial growth factor receptor (VEGFR) and fibroblast growth 
factor receptor (FGFR) inhibitor, SU 5402, has been chosen to block FGF signal.  
All treatments have been done at 24 hpf, when GFP is widely expressed by all the analysed 
transgenics. Drugs and dosages are reported in Material and Methods.  
Considering GFP stability observed during reporters validation, drugs treatment have been 
conducted for two days.  
A photo of an entire larva together with magnified views of anterior and posterior body parts 
have been taken at the epifluorescent microscope for each drug treatment (Fig. 27, 28,   S5, S6, 
S7 and S8). A general network of putative interactions can be inferred using these preliminary 
data (Fig. 29).  
Some of them confirmed what is known from literature: 
- the inhibitory effects of Shh on BMP (Marcelle et al., 1997) (Motoyama and Aoto, 2000)  
- the inhibitory effect of Wnt on BMP signal (Nakashima et al., 2005) (Baker et al., 1999) 
(Marcelle et al., 1997) 
- the inhibitory effect of Notch on both Wnt and Shh (Wang et al., 2009) (Deregowski et al., 
2006) (Kim et al., 2012) (Roy et al., 2014) 
Other treatments have given apparent contrasting results depending on the tissue. For example, 
the inhibition of FGF signal causes a drastic reduction of GFP in the tg(7xTCF-Xla.Siam:GFP)ia4 
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larvae, except for the lateral line that appears to be stimulated. It is known that blocking FGF 
signalling in the pre-somitic mesoderm prevents Wnt activation (Wahl et al., 2007). On the other 
hand, FGF plays an opposite role during the lateral line formation. The Wnt/β-catenin inhibitor 
dikkopf1 (dkk1), which is expressed immediately adjacent to the leading zone of Wnt/beta-
catenin signalling, is absent upon FGF inhibition. Therefore, there is a negative feedback loop in 
which FGF signalling inhibits Wnt/beta-catenin through the inhibitor dkk1, thus spatially 
restricting Wnt/beta-catenin to the leading zone in the migrating primordia (Ma and Raible, 
2009). A further example is offered by Shh inhibition that determines a decrease of reporter 
expression in the tg(7xTCF-Xla.Siam:GFP)ia4 larvae and, concomitantly, an expansion of GFP+ 
cells in the heart region and the increase of reporter expression in the lateral line (Fig. 31). Wnt 
pathway plays an important role in the development of sensory organs, such as the lateral line. 
Ken Iwatsuki et al. have demonstrated that blocking Shh up-regulates Wnt signalling in cultured 
tongue explants and enhances papillae formation (Iwatsuki et al., 2007).  
In some cases, inhibition and stimulation of the same chemical signal do not have opposite 
effect. For example, BIO-induced Wnt stimulation has clearly reduced BMP-associated reporter 
expression. On the other hand, IWR-1-induced Wnt inhibition did not significantly increase GFP 
expression in the same reporter line. 
In the "Appendix" chapter some confocal views of treated larvae of tg(12xSBE:EGFP)ia16,  
tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 lines are displayed and can better 
shown some of the revealed interactions (Fig. S7, S8 and S9). 
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Fig. 27. The effects of the inhibitors of the 4 morphogens on tg(12xSBE:EGFP)ia16, 
Tg(BMPRE:EGFP)ia18, tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 lines: GFP 
expression.  Fluorescent lateral views of anterior and posterior body parts of tg(12xSBE:EGFP)ia16, 
tg(BMPRE:EGFP)ia18, tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 larvae  at 3 dpf. Each 
reporter line has been treated at 24 hpf  for 2 days with the inhibitors of the 4 morphogens (BMP, TGFb, 
Wnt and Shh).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28. The effects of the other drugs tested on tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, 
tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 lines: GFP expression.  Fluorescent 
lateral views of anterior and posterior body parts of tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, 
tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 larvae  at 3 dpf. Each reporter line has been 
treated at 24 hpf for 2 days with Wnt and Shh agonists and the inhibitors of Notch and FGF signalling 
pathways.  
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Fig. 29. Epistatic interactions extrapolated from rapid observation of treated larvae of the reporter 
lines at the epifluorescent microscope: scheme.  This diagram represents the epistatic interactions 
occuring among the 4 morphogens together with Notch and FGF pathways. This interactions has been 
derived from the fluorescence observation of reporter lines larvae treated with agonists and antagonists of 
the studied pathways. Purple arrows indicate not clear interactions.  
 
4.b Analysis of GFP transcript levels through mRNA in situ hybridization                                     
The previously described observations of GFP expression have been performed on living larvae. 
This approach makes possible a relatively easy analysis of drugs treatment, but it takes time to 
visualize any modified reporter expression because of the stability of the fluorescent molecule 
itself. This can expose the treated larvae to stress conditions that can alter the specific effect of 
each drug.  
In contrast to protein, mRNA is less stable and permits a shorter period of treatment and an 
easier and clearer evaluation of the results. Therefore, GFP mRNA level has been checked for 
each treated transgenic larva at 48 hpf through RNA in situ hybridization (ISH) (Fig. 30, 31, 
S12, S13 and S14). Once more, a general scheme of pathways interactions has been inferred 
from these data (Fig. 32).  
70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
Fig. 30. The effects of the inhibitors of the 4 morphogens on tg(12xSBE:EGFP)ia16, 
tg(BMPRE:EGFP)ia18, tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 lines: ISH for 
EGFP.  Lateral views of anterior and posterior body parts of tg(12xSBE:EGFP)ia16, 
tg(BMPRE:EGFP)ia18, tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 larvae  at 3 dpf. Each 
reporter line has been treated at 24 hpf for 1 day with the inhibitors of the 4 morphogens (BMP, TGFb, 
Wnt and Shh).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 31. The effects of the other drugs tested on tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, 
tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 lines: : ISH for EGFP.  Lateral views of 
anterior and posterior body parts of tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, tg(12xGli-
Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 larvae  at 3 dpf. Each reporter line has been treated at 24 
hpf for 1 day with Wnt and Shh agonists and the inhibitors of Notch and FGF signalling pathways.  
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Fig. 32. Epistatic interactions extrapolate from ISH for EGFP on treated larvae of the reporter 
lines: scheme.  This diagram represents the epistatic interactions occuring among the 4 morphogens 
together with Notch and FGF pathways. This interaction has been derived from the EGFP ISH 
observation of reporter lines larvae treated with agonists and antagonists of the studied pathways. Purple 
arrows indicate not clear interactions.  
 
This technique confirms what as seen before at the epifluorescent microscope. For some 
treatments, it is still hard to define if there is a general either positive or negative interaction. For 
example, Wnt and TGFb inhibition cause a fluorescence decrease in otic vescicles and eyes in 
tg(BMPRE:EGFP)ia18 larvae, but GFP seems unchanged in the muscles. Wnt signalling controls 
the formation of the sensory organs, such as eye and inner ear. Together with BMP it forms a 
dorsal gradient in the eye. BMP does not need Wnt to be induced, but to be maintained in this 
area (Veien et al., 2008). It is likely that other pathways can counteract the Wnt inhibition in the 
musculature (i.e., BMP itself,). Notably, TGFb effect on BMP pathway was not so evident at the 
epifluorescent microscope. mRNA is faster degraded than protein, therefore GFP changes can be 
easier verified. This aspect let us better understand other interactions, such as TGFb-Notch.  
FGF and Shh inhibitions determine a reduction of GFP expression in tg(7xTCF-
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Xla.Siam:GFP)ia4 larvae, except for the lateral line that is over-activated, as seen at the 
epifluorescent microscope. Notably, mRNA ISH let us overcome the problem of the background 
caused by SU5402. This FGF-inhibitor is fluorescent and make the entire larva green-coloured 
partially hiding the specific GFP fluorescence.  
As observed at epifluorescent microscope, in the tg(7xTCF-Xla.Siam:GFP)ia4 larvae, Shh 
inhibition causes an expansion of GFP+ cells in the heart, not more confined to the cardiac 
valves.  
For Shh-responsive line, ISH has revealed a likely increase of GFP transcript after BMP 
inhibition, in contrast to what has been previously observed at the epifluorescent microscope. 
Furthermore treatment with DAPT seems to decrease GFP mRNA in the musculature (not 
observed before) and to block it in the ventral brain in tg(12xGli-Hsv.Tk:GFP)ia10 larvae, in 
contrast to what has been seen at the epifluorescent microscope.  
 
4.c Fluorescence quantification through ImageJ software                                                            
The analysis of GFP expression through ISH and fluorescence observation let us propose some 
likely interactions among chemical signals. Some of these epistasis are not yet well clear, for 
others (Wnt-BMP, BMP-Shh, FGF-Shh) contrasting results are obtained through the two 
methods. Therefore, the four morphogen reporter lines have been treated with the same drugs 
and fluorescence has been quantified in larvae at 3 dpf through ImageJ software. Data have been 
expressed as integrated fluorescence density of a group of images taken at the epifluorescent 
microscope for each drug treatment. The mean value has been calculated for each group of 
images, normalized respect to the control mean value and plotted on graph together with the 
corresponding standard error (Fig. 33, 34, 35 and 36). These graphs have been used to draw a 
new epistasis network that has been compared with those previously illustrated (Fig. 37).  
Most of the registered interactions have been confirmed. Other data have been useful to 
understand the opposing results. It is also important to evidence that this method considers the 
total GFP production. Therefore, different tissue-related responses of a morphogen to a drug 
cannot be revealed. The effects of FGF and Shh on Wnt efficiently represent this loss of 
information.  
As seen from graphs (Fig. 33, 34, 35 and 36), some differences are not statistically significant 
and treatments should be repeated to have more trustable results. Both the unexpected and not 
statistically values plotted on graphs can be a consequence of the missing activity of the drugs. In 
fact, some drugs, such as IWR-1 and purmorphamine, did not give a statistically significant 
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change in the fluorescence expression of these reporter line for which are specific (Wnt and Shh 
reporter lines, respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 33. Fluorescence quantification of tg(BMPRE:EGFP)ia18treated larvae through ImageJ 
software analysis. Data obtained from fluorescence level measurement have been expressed as 
percentage of integrated density respect to the control (DMSO treated larvae).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 34. Fluorescence quantification of tg(12xSBE:EGFP)ia16treated larvae through ImageJ 
software analysis. Data obtained from fluorescence level measurement have been expressed as 
percentage of integrated density respect to the control (DMSO treated larvae). 
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Fig. 35. Fluorescence quantification of tg(12xGli-Hsv.Tk:GFP)ia11 treated larvae through ImageJ 
software analysis. Data obtained from fluorescence level measurement have been expressed as 
percentage of integrated density respect to the control (DMSO treated larvae).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 36. Fluorescence quantification of tg(7xTCF-Xla.Siam:GFP)ia4 treated larvae through ImageJ 
software analysis. Data obtained from fluorescence level measurement have been expressed as 
percentage of integrated density respect to the control (DMSO treated larvae).  
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Fig. 37. Epistatic interactions extrapolated from fluorescence quantification on treated larvae of the 
reporter lines: scheme.  This diagram represents the epistatic interactions occuring among the 4 
morphogens together with Notch and FGF pathways. These interactions have been derived from 
fluorescence measurements through ImageJ software. Purple arrows indicate not statisticcaly significant 
interactions. 
 
4.d Confocal analyses of reporter double transgenics   
Epistasis revealed by drug treatments of transgenic lines can be better understood considering the 
reciprocal expression of each chemical signal inside a larva during its development. Therefore, it 
has been decided to follow the spatial/temporal interactions of these signals during the first week 
of development. For this aim, the tg(12xSBE:EGFP)ia16 line has been crossed to the other 
transgenics expressing mCherry protein and larvae have been observed at the confocal 
microscope. 12xSBE line mainly expresses fluorescence in the CNS, therefore it can represent a 
simplified model for epistasis study.  
As shown previously, the change of a chemical signal can interfere with another one in different 
way depending on the analysed tissue (i.e. Shh inhibition in tg(7xTCF-Xla.Siam:GFP)ia4 larvae). 
All the registered fluorescence variations in smad3-responsive line were uniform: smad3/TGFb 
seems to be positively regulated by Shh, FGF and Notch and negatively controlled by Wnt.  
Notch reporter line shows a similar expression pattern in the CNS (Fig. 38), where this signalling 
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is known to maintain the stem cell pool surrounding the ventricular zone (Shimojo et al., 2008) 
smad3+ cells are also found near the ventricular zone because of the role of TGFb in the neural 
differentiating process (Fig. 24). It has been also observed that Notch can rule TGFb signals 
(Fig. 34). There might be a reciprocal interaction between Shh and TGFb morphogens in 
cooperation with Notch to regulate the development of the nervous system. 
 
Fig. 38. Notch and TGFb pathways: confocal views.  Double transgenic 
tg(12xSBE:EGFP)ia16/(Tp1bglob:nls-mCherry) larvae observed at the confocal microscope at 1, 2, 3 and 5 
dpf. Colocalizing cells are visible in the neural tube as well as in the hindbrain. 
 
In Shh reporter line the fluorescence is expressed in the ventral side of the CNS and in the slow 
muscle fibers. Shh is known to direct the differentiation of motor neurons, oligodendrocytes and 
V3 and V3 interneuron populations (Roelink et al., 1995) (Ferent et al., 2013) (Litingtung and 
Chiang, 2000). TGFb can cooperate with this signal to promote differentiation and this thesis 
seems to be supported by the presence of some colocalizing cells in the ventral part of CNS (Fig. 
39). Nowadays, no interactions have been observed between these pathways in the CNS. 
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Notably, we envisage that the effects of TGFb inhibition on motorneurons and oligodendrocytes 
can be at least partially mediated by Shh signalling. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 39. Shh and TGFb pathways: confocal views.  Double transgenic tg(12xSBE:EGFP)ia16/(12xGli-
Hsv.Tk:nls-mCherry)ia10 larvae observed at the confocal microscope at 1, 2, 3 and 5 dpf. Some 
colocalizing cells are visible in the ventral neural tube.  
 
 
Wnt and BMP are respectively involved in neurogenesis and gliogenesis. In CNS they are far 
from the ventricular zone. TGFb can be negatively controlled by Wnt signalling as confirmed by 
the absence of colocalizing cells in this area (Fig. 40 and 41).  
On the other hand, both BMP and Wnt seem to be coexpressed with TGFb in the mesoderm tail. 
Fluorescence observation and ISH show a positive regulation of BMP and Wnt reporter by 
TGFb.  
Activin and nodal are known to induce and maintain mesoderm, Wnt and FGF are required for 
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its maintainance and BMP is responsible for mesoderm patterning, promoting the formation of 
the ventral mesoderm (Kimelman, 2006) (Heasman, 1997). A common Wnt inhibitor, Dkk-1, is 
known to be induced for TGFb-mediated Xenopus mesoderm induction. Colocalization of Wnt 
and BMP+cells with smad3+ cells in the tail mesoderm complies perfectly with this known role 
of these pathways.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 40. Wnt and TGFb pathways: confocal views.  Double transgenic tg(12xSBE:EGFP)ia16/(7xTCF-
Xla.Siam:nls-mCherry)ia5 larvae observed at the confocal microscope at 1, 3, 4 and 5 dpf. Colocalizing 
cells have been observed in tail mesoderm at 24 hpf.  
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Fig. 41. BMP and TGFb pathways: confocal views.  Double transgenic 
tg(12xSBE:EGFP)ia16/(BMPRE:nls-mCherry)ia17 larvae observed at the confocal microscope at 1, 2, 3 and 
5 dpf. Some colocalizing cells have been detected in tail mesoderm at 24 hpf.  
 
5. An example of in vivo use of the reporter lines for in vivo study of pancreas development 
The validation of reporter lines and the observation of the fluorescence expression during early 
larval development at epifluorescent microscope have been an important precondition to all the 
following in vivo study. As our laboratory is focused on pancreas development, we have used the 
four morphogen reporter lines to see which of them are active in pancreas, at which 
developmental stage and which cell types require them.  
For this aim, we have mated each reporter line expressing either GFP or mCherry with 
transgenic lines expressing either dsRED or GFP under the control of pancreatic genes, such as 
nkx2.2a (tg(nkx2.2a:mEGFP)vu17), ins (tg(-1.2ins:HSV.UL23-GFP)ia8and tg(ins:dsRED)m1018), 
glu (tg(gcga:GFP)ia1), Ptf1a (tg(−5.5Ptf1a:DsRed)ia6) and NeuroD (tg(-2.4kb neurod:EGFP)). 
These genes are specifically expressed in either exocrine (Ptf1a, (Zecchin et al., 2004)) or 
endocrine (ins, (Moro et al., 2009)) pancreas, in mature cells (ins in β-cells, glu in α-cells and 
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Nkx2.2a in the intrapancreatic duct, (Pauls et al., 2007)) or in precursors (NeuroD, (Flasse et al., 
2013)).  
A fine observation of the previously described double transgenics has been done at the confocal 
microscope till 30 dpf.  
During the early larval development, both Wnt and TGFb reporter lines seem to be not active in 
pancreas.  
On the other hand, Shh signalling seems to be active in early development of the main pancreatic 
islet till 3 dpf. Some reporter expressing cells colocalize with beta-cells, pointing to a role of Shh 
in the differentiation of these kind of cells (Fig. 42).    
 
 
 
 
 
 
 
 
Fig. 42. Shh signalling pathway is active in the main pancreatic islet.  Confocal views of double 
transgenic tg(12xGli-Hsv.Tk:EGFP)ia11/(ins:dsRED)m1018 larvae observed at the confocal microscope at 
2, 4 and 8 dpf. A partial colocalization has been observed at 2 and 4 dpf, whilst no Shh+ cells could be 
detected at 8 dpf.  
                                                            
Interesting data have obtained through BMP reporter line observation. Reporter-expressing cells 
has been individuated both in endocrine (Fig. 43 and 44) and exocrine (Fig. 45) pancreas at 
roughly 3 dpf. At 4 dpf these cells form vessel-like structures extending throughout the pancreas. 
These cell types do not colocalize with any of the pancreatic markers described before. A such 
kind of network seems to characterize the pancreatic vasculature. To confirm this hypothesis, the 
tg(BMPRE:nls-mCherry)ia17 line has been crossed to tg(kdrl:GFP)la116 line. Kdrl is specifically 
expressed in endothelium (Brown et al., 2000). BMP and Kdrl-associated reporters expression 
perfectly matches in the pancreas (Fig. 46). However, a more general observation of these two 
reporters has shown us that BMP is not associated to all the vessels irrorating a zebrafish larva. 
For instance, colocalization has been observed in pancreas and intersegmental vessels, but not in 
liver.  
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A more detailed analysis of the role of BMP in angiogenesis has been performed in the pancreas. 
Although vessels come in contact with the endocrine pancreas at roughly 36 hpf (Fig. S15), no 
traces of BMP-regulated reporter expression has been detected in this area before 72 hpf. 
Therefore, it is possible to affirm that BMP is active in pancreatic vessels, but it seems to not be 
involved in vessel formation.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 43. BMP signalling pathway is active in the pancreatic islet, but it is not expressed by alpha-
cells (Glu), pancreatic duct (Nkx2.2a) and endocrine precursor cells (NeuroD).  Confocal views of 
double transgenic larvae obtained maiting tg(BMPRE:nls-mCherry)ia17 to tg(gcga:GFP)ia1, 
tg(nkx2.2a:mEGFP)vu17 and  tg(-2.4kb neurod:EGFP). No colocalizing cells have been noted during the 
first month of larval development.  
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Fig. 44. BMP signalling pathway is active in pancreatic vasculature system irrorating both 
endocrine and exocrine pancreas.  Confocal views of double transgenic 
tg(BMPRE:EGFP)ia18/(ins:dsRED)m1018 and tg(BMPRE:nls-mCherry)ia17/(-1.2ins:HSV.UL23-GFP)ia8 
larvae observed at the confocal microscope at 2, 4, 8, 15, 20 and 30 dpf. The partial colocalization 
observed with the tg(ins:dsRED)m1018 is a consequence of the dsRED bleed-through into the GFP channel. 
In fact, no colocalizing cells have been noted using the tg(-1.2ins:HSV.UL23-GFP)ia8 and 
tg(BMPRE:EGFP)ia18 lines.   
 
 
 
 
 
 
 
 
 
Fig. 45. BMP signalling pathway is active in pancreatic vasculature system irrorating both 
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endocrine and exocrine pancreas.  Confocal views of double transgenic tg(BMPRE:nls-
mCherry)ia17/(Ptf1a:GFP) and tg(BMPRE:EGFP)ia18/(−5.5Ptf1a:DsRed)ia6 larvae observed at the 
confocal microscope at 8, 10, 15, 20 and 30 dpf.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 46. BMP signalling pathway is active in pancreatic vasculature system irrorating both 
endocrine and exocrine pancreas.  Confocal views of double transgenic tg(BMPRE:nls-
mCherry)ia17/(Ptf1a:GFP) and tg(BMPRE:EGFP)ia18/(−5.5Ptf1a:DsRed)ia6 larvae observed at the 
confocal microscope at 8, 10, 15, 20 and 30 dpf.  
 
 
5.a BMP and angiogenesis during pancreas development 
To clarify the role of BMP signalling in the pancreatic vasculature, double transgenic 
tg(ins:dsRED)/(BMPRE:EGFP)ia18 and tg(ins:dsRED)/(kdrl:GFP)la116 animals have been treated 
with LDN193189, an ALK2, ALK3, ALK6 receptor inhibitor, at 1 and 2 dpf.  
The effects on β-cells development and pancreatic vasculature formation have been observed at 
the epifluorescent and confocal microscopes at 3, 5 and 6 dpf.  
Observation at the epifluorescent microscope (Fig. 47) demonstrates the efficacy of the BMP 
inhibition in both double transgenics, as visible from the decrease of BMP-associated 
fluorescence and the malformed structures such as maxillary and mandibular processes and 
pharyngeal arches. It is also appreciable a misplacement of the main islet, that it is not properly 
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moved on the right lateral side of the larva at 6 dpf, but it is retained nearer the trunk.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 47. BMP signalling inhibition at 24 and 48 hpf leads to a failed movement of the pancreatic islet 
to the later side. Fluorescent lateral views of double trangenic tg(BMPRE:EGFP)ia18/(ins:dsRED)m1018 
larvae treated at 1 and 2 dpf with an Alk2 and 3 inhibitor and observed at 3 5 and 6 dpf.   
 
A better comprehension of the treatment has been obtained at the confocal microscope. In the 
double transgenics tg(ins:dsRED)/(BMPER:EGFP)ia18, no BMP-responsive cells was evident 
during the entire treatment in larvae treated at both 1 and 2 dpf (Fig. 48). No relevant changes of 
the main islet size are visible. Notably, beta-cells failed to move laterally, confirming what has 
been noticed at the epifluorescent microscope. Having demonstrated the effect of BMP inhibition 
on the islet formation, double transgenics tg(ins:dsRED)/(kdrl:GFP)la116 animals have been 
treated with the same dose of BMP inhibitor at the same developmental stages.  
In addition to the failed movement of the pancreatic islet in the larva, treatment at 24 hpf causes 
an altered formation of vessels in this area: the anterior mesenteric artery fails to detach from the 
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dorsal aorta and kdrl expression is significantly reduced in 24 hpf treated larvae (Fig. 49 and 
S16). The inhibition at 48 hpf determines an altered development of the vessels, too (Fig. 49 and 
S16). The anterior mesenteric artery delays to form (visible at 5 dpf instead of 4 dpf) and it does 
not properly place, and abnormal branching is visible at the pancreatic islet level. Nevertheless, 
any relevant decrease of kdrl-associated fluorescence has been observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 48. BMP signalling inhibition at 24 and 48 hpf leads to a failed movement of the pancreatic islet 
to the later side. Confocal views of the pancreatic islet in the double trangenic  
tg(BMPRE:EGFP)ia18/(ins:dsRED)m1018 larvae treated at 1 and 2 dpf with an Alk2 and 3 inhibitor and 
observed at 3, 5 and 6 dpf.   
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Fig. 49. BMP signalling inhibition at 24 and 48 hpf causes an anomalous angiogenesis. Confocal 
views of the pancreatic islet in the double transgenic tg(BMPRE:EGFP)ia18/(ins:dsRED)m1018 larvae 
treated at 1 and 2 dpf with an Alk2 and 3 inhibitor and observed at 3, 4 and 5 dpf. BMP inhibition at both 
1 and 2 dpf causes vessel misplacement in the pancreas area and a missed positioning of the islet in the 
left side of the larva. Furthermore, treatment at 1 dpf decreases significantly kdrl-associated GFP 
expression in the islet region.   
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DISCUSSION 
 
 
1. Validation of reporter lines 
Our lab has developed the expertise to create transgenic lines to follow in vivo signalling 
pathways (Moro et al., 2013). Both physiological and pathological mechanisms are ruled by 
chemical signals that are involved in the control of cell proliferation and differentiation.  
Taking advantage of relatively easy genetic manipulation of Zebrafish model, a series of 
transgenic lines have been produced to report some signalling such as BMP, TGFb, Shh and 
Wnt.  
Treatments with specific inhibitors and agonists have shown their specific responsiveness. GFP 
expression is reduced within 24 hpf and almost completely abolished after 2 days of treatment, 
whilst the corresponding mRNA has shown a shorter half-life (6-8 hours) (Fig. 7a, 7b, 7c, 7d, 8a 
and 8b). These aspects have to be considered when performing experiments with these reporters. 
In fact, the chemical stream represents one of the major disadvantages of all reporter transgenic 
lines. This phenomenon is caused by reporter protein stability. As a consequence, dividing cells 
transmit reporter protein to their daughter cells. These are fluorescent without activating that 
chemical signal, responsible for the reporter expression in the original cell. All the conclusions 
extrapolated with these models should keep count of it and be confirmed by assays that evaluate 
reporter mRNA (i.e, mRNA ISH, real time PCR) and/or target genes expression of the analysed 
pathway.  
The tg(7xTCF-Xla.Siam:GFP)ia4 line has been previously validated, characterized and published 
by our lab (Moro et al., 2012). 
BMP and Shh reporter lines are chemically responsive to specific drugs and have a similar 
expression pattern of those created with the same signalling responsive elements (Laux et al., 
2011) (Schwend et al., 2010). 
Therefore, beyond the chemical treatment with specific inhibitors and the observation at both 
epifluorescent and confocal microscope during early larval development, no further analyses 
have been performed on them. The few genetic analyses performed on tg(BMPRE:EGFP)ia18 line 
have been useful to confirm their efficacy and specificity for smad3/TGFb signalling.   
The first part of this thesis project concerns the study of the unpublished 12xSBE line. 
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1.a 12xSBE line: a smad3/TGFb responsive line 
In this work we have developed a zebrafish transgenic line, namely 12xSBE line, responsive to 
smad3/TGFb signaling. Through pharmacological, genetic and molecular characterization we 
have shown that this transgenic line faithfully reproduces smad3 activation and it can be used to 
follow in vivo TGFb signaling, both temporally and spatially at a single cell resolution. 
Treatment with chemical Alk4- and Alk5-inhibitors (SB-431542 and LY-364947) has proved 
that blocking type-I receptors, specifically involved in TGFb signaling activation, inhibits 
reporter expression: the transcription of the reporter gene is abolished within 8 hours of 
treatment with SB-431542 (Fig. 7d-E), whilst fluorescence level is reduced after 1 days of 
treatment (data not shown) and completely blocked after 2 days (Fig. 7d-A-D'). Moreover, 
through fluorescent immunohystochemistry we have demonstrated that reporter expression is 
consecutive to nuclear localization of phosphorylated smad3 (Fig. S18).  
Genetic and molecular approaches gave us more specific details regarding reporter expression in 
the transgenic line. GFP expression of tg(12xSBE:EGFP)ia16 line has been observed in two 
different genetic background: one-eyed-pinhead (oep) and chordin (dino) mutants. One-eyed-
pinhead (oep) is an EGF-CFC protein that functions as cofactor necessary for nodal/TGFb 
signalling. In the transgenic line, GFP expression was absent in the cardiac mesoderm of oep 
mutants (Fig. 9B-B'''). No significant changes have been observed in the neural tube, where 
smad3 activity seemed to be independent from nodal ligands. Although Aquilina-Beck et al. 
have demonstrated that nodal signalling is involved in anterior neural tube closure and 
neuroectoderm specification (Aquilina-Beck et al., 2007) and it acts through smad2/3 (Jia et al., 
2009), it is in facts dispensable for neural induction (Jia et al., 2009).  
The mutation of this cofactor did not affect reporter expression in tg(BMPRE:EGFP)ia18 line. 
Nodal signalling can interact with BMP signalling during the embryonic development, but its 
impairment do not block BMP-mediated GFP expression (Fig. 11). Therefore, we can affirm that 
BMPRE line responds to BMP signals and oep mutant line correctly represent an altered TGFb 
signal.   
As BMP and TGFb show a similar transduction pathway distinguished for different types of 
receptors, r-smads and their relative target sequence in the genome, we have tested effects of 
BMP activation on smad3-mediated reporter expression by analysing mutants of chordin, a 
bmp2/4 antagonist. Albeit it has been demonstrated that smad2/3 upregulate bmp inhibitors, such 
as chordin, and BMP inhibition is important for neural induction (Jia et al., 2009) (Cruz et al., 
2010), levels of GFP expression in the neural tube of dino mutants compared with that of sibs 
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confirming the specificity of 12xSBE transgenic line for TGFb-associated r-smads (Fig. 9C-C''').  
Morpholino-mediated knock-down of r-smads and co-smad has confirmed the specificity of both 
tg(12xSBE:EGFP)ia16 and tg(12xSBE:nlsmCherry)ia15 lines for smad3/4.  
Smad4 is needed for both BMP and TGFb signalling activation (Aristidis Moustakas et al., 
2001). The absence of reporter expression in both 12xSBE and BMPRE lines has given us an 
important proof that TGFb superfamily signalling activates both reporter lines. Notably, this 
common effect confirms the efficacy of the chosen smad4 morpholino.  
Concerning r-smads morphants, the transgenic lines seemed to be sensitive to both zebrafish 
isoforms of smad3: smad3a and smad3b. When embryos were injected with smad3a morpholino, 
they failed to express both EGFP and mCherry (Fig. 12 and S2). On the other hand, knock-down 
of smad3b strongly inhibited reporter expression, which was limited to the very end of the tail. 
We envisage two possible explanations for these results: a) higher efficacy of smad3a 
morpholino respect to the smad3b one; b) different levels of genetic additivity for the two loci 
allowing smad3a to partially compensate for smad3b absence in the neural tube, but not 
viceversa.  
Albeit the transgenic lines have been designed with smad3-responsive sequence (Dennler et al., 
1998), the injection of smad2 morpholino inhibited reporter expression in the cardiac mesoderm 
and partially interfered with fluorescence in the tail region (Fig. 12 and S2). This might be a 
consequence of smad2/3 interaction. In fact, smad2 can heteromerize to smad3, translocate to the 
nucleus and together cooperate to activate the expression of smad3 target genes (Lan, 2011) 
(Miguez et al., 2013). In contrast to what has been seen for smad2 and 3 in the chicken neural 
tube (Lan, 2011) (Miguez et al., 2013), knock-down of smad2 determines a reduction of 
CAGA12 box-depending reporter expression. However, the different techniques used to inhibit 
and study smad2 in zebrafish (this work) and chicken (Miguez et al., 2013) such as 
morpholino/short-hairpin RNA, microinjection of eggs/electroporation of neural tube, stable 
line/transient expression, can explain the differences. Alternatively, smad2-3a-3b and 4 interact 
in different ways in neural tube formation of the two animals. In any way, the zebrafish 12xSBE 
line will be a useful tool, together with a still missing smad2 reporter line (possibly based on 
activin response elements, ARE) (Chen et al., 1996), to dissect the functional interactions 
between the TGFb specific transcriptional effectors in vivo.  
Characterization of tg(12xSBE:nlsmCherry)ia15 line has been completed overexpressing smad7 
and smad3b. Overexpression of smad7 caused a drastic reduction of reporter expression in all 
domains of activity (Fig. 15A-A''). On the other hand, overexpression of smad3b by plasmid 
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injection has led to a mosaic expression of smad3b and, consequently, of the reporter (Fig. 15C-
C''). Notably, it was evident an ectopic activation of mCherry in smad3-competent cells (i.e. the 
muscle) supporting the idea that muscle cells do not possess epigenetic mechanisms to inactivate 
this pathway. 
Furthermore, the reporter expression correlates to the zones of release of tgfb2 (Chen and 
Kimelman, 2003) and tgfb3 (Thisse and Thisse, 2004): notochord, pectoral fins and lens. These 
data underline the dependence of the reporter from tgfb ligands. 
 
 
2. Smad3-mediated neurogenesis in Zebrafish1: in vivo study through a smad3-responsive 
transgenic line 
Confocal observation of the transgenic line showed that in the neural tube the reporter is active 
in cells surrounding the ventricular zone (Fig. 19E''). This area is known to be a region in which 
genetic signals lead neural progenitor cells to exit cell cycle and start differentiation (Schmidt et 
al., 2013). To understand the role of smad3 activation in this area, the 
tg(12xSBE:nlsmCherry)ia15 line has been crossed to some transgenic lines expressing GFP in 
different neuronal and glial cells: tg(Ngn1:GFP)sb1, tg(-2.4kb neurod:EGFP), tg(gfap:GFP)mi2001, 
tg(mnx1:GFP)ml2 and tg(Nkx2.2a:mGFP)vu17. The quantitative analysis of colocalization has 
shown that reporter expression was mainly activated in differentiating neurons (NeuroD+ cells) 
and glia (GFAP+ cells) (Fig. 22). Colocalization of smad3-responsive cells with NeuroD+ and 
GFAP+ cells rose up between 1 and 2 dpf (Fig. 21B''' and C'''), during axon growth and the 
secondary neurogenesis. A significant degree of colocalization has been measured with Ngn1+ 
cells. From these observations we have concluded that TGFb signalling could be active in ex-
progenitor cells, which exit the cell cycle and start differentiating. Therefore, late progenitors, 
such as Ngn1+ cells, expressed both the differentiation marker (GFP) and the reporter 
(mCherry). On the other hand, differentiated cells seemed to be smad3/TGFb negative. 
Nevertheless, for motor neurons (Mnx1+ cells) and oligodendrocytes (Nkx2.2a+ cells), a 
significant increase of Manders’ coefficient has been observed between 3 and 4 dpf, possibly for 
a mCherry retention trail in differentiated cells. This theory has been confirmed analyzing TGFb 
evolution in the tail of double transgenic embryos at 24 hpf by using somites as timeline (Fig. 
22). At the onset of TGFb signalling (t=0), progenitor cells (Ngn1+ cells) expressed TGFb signal 
(Fig. 22A'''). This colocalization has been observed and maintained with differentiating neuronal 
(NeuroD+ cells) and glial (GFAP+ cells) cells (Fig. 22B''' and C'''). Motor neurons (Mnx1) and 
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oligodendrocytes (Nkx2.2a) did not show significant colocalization at any of the time-points 
analysed (Fig. 22D''' and E''').   
The hypothesis of TGFb involvement in differentiating process might comply with its role in the 
control of epithelial-to-mesenchymal transition (EMT) (Song, 2007). The smad3 control of 
proliferation is crucial during early-postnatal differentiation of cerebellar neurons into 
postmitotic neurons, activating cyclin-dependent kinase inhibitors p21, p27 and markers of 
neuronal differentiation (Uwe and Thomas, 2013). A clear inhibitory function of smad3 on 
neural progenitors proliferation was shown in chicken developing spinal cord, where smad3 also 
promotes differentiation of selected neurons and glia (Garcia-Campmany and Marti, 2007). Both 
immunohistochemistry for phospho-hystone3 on smad3a morphant embryos at 24 hpf (Fig. 23A-
B') and LY364947-treated larvae at 48 hpf (Fig. 23C-D') and EdU proliferation assay on 
embryos treated with Alk5 inhibitor, LY364947, (Fig. 23E-F') showed a massive increase of 
proliferating cells in many tissue compartments, included NS. All these experiments have 
confirmed that smad3/TGFb regulates negatively cell cycle and is inactive in proliferating cells. 
Colocalization studies have indicated that smad3-responsive cells mainly correlate to 
differentiating cells rather than proliferating and mature cells in NS. Pulse and chase EdU 
proliferation assay has confirmed that on 24hpf tg(12xSBE:EGFP)ia16 embryos GFP-expressing 
cells are mainly post-mitotic (Fig. 23G-H'). We can conclude that smad3 acts on cell cycle by 
stopping cell proliferation and it is expressed postmitotically at 24 hpf.  
After having demonstrated that smad3 is expressed in NS by differentiating cells, we have 
carried out some functional in vivo studies blocking TGFb activity in embryos of the transgenic 
lines used for colocalization measurement: tg(Ngn1:GFP)sb1, tg(-2.4kb neurod:EGFP), 
tg(gfap:GFP)mi2001, tg(mnx1:GFP)ml2 and tg(Nkx2.2a:mGFP)vu17. Both genetic and 
pharmacological TGFb inhibition has led to similar conclusions (Fig. 24). Smad3/TGFb 
signalling is important for maintaining a balance between progenitor and mature cells. Turning 
down this signal has caused an increase of undifferentiating cells (Ngn1+ cells) and a decrease of 
mature neural and glial cells (Mnx1+ cells and Nkx2.2a+ cells). When the signalling has been 
blocked immediately after the fertilization, smad3 inhibition manifested its effect mostly on the 
neural markers of the tail region. This might depend on the role of smad3-mediated signalling in 
the neuroectoderm posteriorization (Jia et al., 2009). On the other hand, when the smad3 signal 
has been inhibited after 24hpf, the effects were visible in the entire larva (Fig. 25). This might be 
a consequence of the smad3 role in the secondary neurogenesis (from 2dpf) and in axogenesis 
process (from 14 to 24 hpf) (Chapouton et al., 2010). Concerning motor neurons, TGFb 
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inhibition affected their number as well as the somata positioning in the neural tube and their 
proper axons formation. Results presented here have shown that TGFb signalling is important for 
differentiation and positioning of motor neurons in the neural tube during early development. 
This might be a direct consequence of an altered smad3-dependent EMT in the progenitors due 
to the effects of TGFb on extracellular matrix (ECM) and GDNF production (Gomes et al., 
2005) (Ho et al., 2000). Another conclusion from our studies is about smad3a and 3b role in the 
nervous system development: both smad3 isoforms might recognize CAGA box and direct 
reporter expression in the neural tube. Functional in vivo experiments on trasgenics confirmed 
that the 2 isoforms are equally involved in neurogenesis as the effects on the neural markers 
seemed to be very similar. Moreover, coinjection of the 2 morpholinos did not cause a further 
impairment in the neural tube formation, while embryo body appeared to be more severely 
altered (shortened embryo, smaller malformed head). This let us assert that at least in the neural 
tube formation smad3a and 3b have similar levels of addictive genetic effects.  
Through these assays, we can assert that 12xSBE line is responsive to smad3/TGFb signaling 
drugs: reporter expression depends on smad3 activation and it is inhibited by smad7 in a cell-
autonomous manner. Furthermore, both Zebrafish smad3 isoforms might recognize CAGA box 
with similar efficacy and equally participate to the differentiation of the neural tube. According 
to these data, smad3-mediated TGFb signalling seems to have a role in CNS development by 
controlling mature cells positioning, axons formation and most importantly and primarily, the 
regulation of the progenitor-precursor switch.  
Furthermore, this work wants to represent an alternative approach to study biological 
mechanisms. The current paradigm of dissecting gene function usually starts with gene 
identification, the definition of its expression domain, followed by knockdown and description of 
the phenotypic effects. However, this paradigm falls short if one considers that understanding 
gene function and phenotypes must necessarily entail the precise identification of the cells in 
which the gene or pathway are operating, and appreciation of the temporal dynamic of gene 
activity computed by cells in real tissues. The approach used in this work attempts to surpass this 
limitation: we started from the strongest expression of a functional reporter to identify the tissues 
in which a transcription factor (Smad3) is activated by a main developmental signalling pathway 
pathway (TGFb). Here we analysed the functions of Smad3 in previously underinvestigated 
tissues and cell types - the periventricular cells of the neural tube - that we reveal as main targets 
of TGFb ligands emanating from the notochord; in other words, targets of pleiotropic 
morphogens emanating from a different tissue, endowed of multiple inducing properties. 
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3. Epistasis: how to study genetic signals interaction in vivo 
Each of the development stages involves induction, proliferation, locomotion, and cell type or 
subtype determination, but also prevention of inappropriate cell formation. To reach this goal, a 
precise mechanism is established, by which each signalling pathway plays its roles exactly and in 
coordinative manners according to time, space and intensity.  
The last part of my project thesis illustrates an innovative approach to this topic. The epistatic 
relations of the four morphogens (BMP, TGFb, Shh and Wnt) and Notch signalling have been 
analysed through our reporter lines. Together with these chemical signals FGF pathway has been 
also partially analysed using a FGF inhibitor, SU5402.  
As visible from Fig. 50, molecular networks inside cells are dynamic and complex. A way to 
understand their logic is to dissect networks in subgroups of interactions, so called motives. This 
approach let us individuate some feed-forward loops (FFLs), characterized by three transcription 
factors (x, y and z) and three regulatory interactions: x acts directly on z and indirectly 
throughout y. FFLs can be divided in two groups: 4 coherent (if x acts in the same way on z, 
directly and indirectly) and 4 incoherent interactions (if x has opposite results on z acting directly 
and indirectly) (Macia et al., 2009). FFLs types appear with different frequency in the biological 
systems. Notably, the most common FFLs are: coherent type I and incoherent type II. As visible 
in Fig. 50, 5 out of 8 distinguishable FFLs are incoherent: Shh-TGFb-BMP; Notch-Shh-TGFb; 
FGF-Shh-Wnt; Shh-BMP-Wnt; Wnt-BMP-Shh. 3 out of 8 are coherent: FGF-TGFb-BMP; FGF-
Wnt-Shh; BMP-Shh-Wnt. Among the 8 FFLS, 2 are type I coherent interactions. The others 
appear in biological systems with a low frequency. This let us suppose that some of revealed 
interactions might not be realistic. These might be results of not specific drug effects (i.e. 
SU5402 blocks both FGF receptor and VEGF receptor). Furthermore, some epistatic relations 
might not be the result of a direct interaction between the observed signals, but they might 
require a "third player". For instance, it has been observed a stimulatory effect of BMP on Shh 
signalling. Nevertheless, in various tissues and developmental processes, BMP signalling limits 
Shh activity (Patten and Placzek, 2002) (Piedra and Ros, 2002) (Zhang et al., 2000), rather than 
stimulates it.  
All the incoherent feed-forward loops can be considered as a way of the biological system to 
maintain a dynamic equilibrium. For example, Notch signalling can directly stimulate TGFb 
promoting neuronal differentiation. To limit this process, Notch acts on Shh signalling blocking 
it. Shh is known to be involved in neuronal differentiation. Our data show a positive interaction 
between Shh and TGFb. Therefore, Notch-mediated Shh inhibition can limit TGFb-induced 
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neural differentiation.  
Another interesting FFL involves FGF, Wnt and Shh: FGF inhibits Wnt signalling through Shh 
activation, but it also stimulates directly Wnt itself. This might be the mechanism regulating the 
lateral line formation. FGF signalling inhibits Wnt/beta-catenin through the inhibitor dkk1 and 
limits Wnt/beta-catenin activity to the leading zone in the migrating primordia (Ma and Raible, 
2009). However, Wnt should also be stimulated to promote lateral line formation. FGF-mediated 
control of this organ development might consist of opposite balanced effects.  
Notably, the relative high number of incoherent type FFLs can reflect the contrastasting data 
found in literature for many of the observed interactions. All these pathways are implicated in 
various biological processes. They are often expressed in overlapping and/or complementary 
manners, temporally and spatially (Fig. 38, 39, 40 and 41). Different studies have demonstrated 
that a pair of signalling pathways can act in a synergistic or antagonistic way, depending on the 
cellular contest (i.e. the interaction between Wnt and BMP, (Itasaki and Hoppler, 2010). This 
may be the consequence of multiple players action. Therefore, a better comprehension and 
analysis of signalling epistasis should consider other chemical signals often involved in the 
embryogenesis, such as retinoic acid and FGF signals, too.  As seen before, this can make hard to 
extrapolate a general model of signalling interactions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 50. Epistatic interactions extrapolated from fluorescence quantification on treated larvae of the 
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reporter lines: scheme.  This diagram represents the epistatic interactions occuring among the 4 
morphogens BMP, TGFb, Wnt and Shh together with Notch and FGF pathways. These interactions have 
been derived from fluorescence measurements through ImageJ software. Purple arrows indicate not 
statisticcaly significant interactions. 
 
Another strategy to study signalling interactions is observed their reciprocal spatio-temporal 
expression within the embryo. For this aim, 12xSBE:GFP line has been crossed to the other 
reporter lines expressing mCherry. Shh and Notch signalling can be active with TGFb signalling 
in the same cells. This justifies the positive effects of both signalling on TGFb pathway. On the 
other hand, both BMP and Wnt are not co-expressed with TGFb signalling in the neural tube and 
therefore, Wnt has an inhibitory effect, whilst BMP does not show any epistatic interaction on 
TGFb. Notably, a significant colocalization has been observed between Wnt/BMP and TGFb 
signalling in the tail mesoderm. Since GFP is mainly expressed in the nervous system in 12x 
SBE line, no antagonist effects of BMP and Wnt have been observed. On the other hand, both 
BMP and Wnt reporter lines are active in mesoderm. TGFb activation in this tissue can result in 
a stimulatory effect.  
The interactions revealed through chemical treatments and reporter lines are confirmed by 
literature in some cases, as explained in the "Results" chapter. For example, Notch and Wnt 
signals are closely related in the brain (Hayward et al., 2005). Shh from floor plate and 
notochord limits Wnt activity to dorsal part of the myotome (Marcelle et al., 1997). On the other 
hand, no data have been registered regarding the induction of smad3/TGFb by Shh pathway. 
Three approaches have been used to observe signalling epistasis: fluorescence observation, GFP 
mRNA ISH and fluorescence quantification. Looking at both GFP mRNA and protein expression 
let us identified any tissue-specific interactions (i.e. FGF and Wnt in the lateral line). On the 
other hand, the fluorescence quantification simplifies the epistatic relations letting us to propose 
a clearer epistasis model. Even if this last method of data analysis causes a loss of information, it 
is based on mathematical analysis and, therefore, is the most trustable and objective.  
 
4. An example of use of the reporter lines for in vivo study of pancreas development 
The use of the four morphogen lines created in our lab has made possible to observe in vivo 
which signalling is active during early larval pancreas development. Most of the information 
concerning morphogens and pancreas are referred to early development (pre-somitogenesis). 
Less is known about their action in later stages.  
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For this reason, our attention has been focused on the first month of larval development: from 2 
till 30 dpf.  
We do not reveal any smad3/TGFb activation during this lag-time. Even if smad 4 is expressed 
in murine neonatal and adult pancreatic islets (Hua and Sarvetnick, 2007), the activation of this 
transcription factor seems to be associated to BMP and not to smad3-medited TGFb signalling. 
Furthermore, in our lab Schiavone et al. have observed the expression of the smad3-associated 
reporter in mutated Kras-induced pancreatic tumors (Schiavone, M. et al., 2014). In fact, TGFb 
is known to have both a tumor-suppresor and oncogenic activity. It promotes apotosis and 
control inflammatory process, but it also stimulate epithelial-to-mesenchymal transition and 
neoangiogenesis (EMT) that in turn facilitate the invasiveness of the tumors (de Caestecker et 
al., 2000).  
Although some members of the Wnt pathway have been identified and/or associated to the 
pancreas development (Papadopoulou and Edlund, 2005) and loss of function of TCF7L2 blocks 
glucose-stimulated insulin secretion (Liu and Habener, 2010), no Wnt-dependent reporter 
activation has been registered in the considered lag-time.  
Some explanations can be proposed. The tg(7xTCF-Xla.Siam:GFP)ia4 line is able to report only a 
part of the canonical beta-catenin-mediated Wnt signalling. Furthermore, mutational analyses of 
TCF target enhancers show that TCF sites might be not sufficient for the gene activation in vivo 
(Barolo, 2006). More TCF-binding sites might be needed to reveal the Wnt signalling activation 
in the pancreas, too. 
More interesting results have been obtained with tg(12xGli-Hsv.Tk:GFP)ia9 and 
tg(BMPRE:EGFP)ia18 lines. At roughly 2-3 dpf, few Shh+cells have been identified in the 
pancreatic islet. Notably, this signalling seems to be active in some beta-cells. As said before, 
Shh promotes migration and differentiation of endocrine precursor cells until early gastrulation 
contrasting BMP repressive effects. Later, it antagonizes retinoic acid and inhibits endocrine cell 
differentiation (Tehrani and Lin, 2011). Therefore, it does not surprise to find Shh-induced 
fluorescence in some beta-cells. However, the study of its role during early organogenesis is still 
in progress.  
4.a BMP and angiogenesis 
BMP is known to repress pancreatic cell fate at the expense of the liver cell fate and it also 
negatively regulates beta-cells differentiation.  
BMP-mediated reporter expression appears in pancreas at roughly 3dpf and it is initially 
confined to few cells in the islet area. Between 5 and 6 dpf GFP starts to be expressed in vessels 
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that extend from the head to tail of the pancreas. Nevertheless, kdrl-associated GFP is detectable 
in the pancreatic islet beyond 24 hpf. According to this observation, vasculogenesis in Zebrafish 
pancreas seems to be BMP-independent. On the other hand, BMP signal seems to correlate to 
angiogenesis. Furthermore, it is known that BMP signal impairment causes severe vascular 
defects in mice: missing endothelial differentiation and consequential hemorrhage, and improper 
vessel formation (Yasunaga et al., 2011). pSmad1/5/8-mediated BMP signal has been found in 
endothelial cells (Ahnfelt-Ronne et al., 2010) of vessels irrorating pancreas and its inhibition 
leads to an increase of differentiating endocrine precursors and a misplacement of the nearby 
omphalomesenteric vein.  
Our functional study of vascular system in pancreas does not show any significant alteration of 
beta-cells formation: double transgenic larvae, tg(kdrl:GFP)la116/(BMPER:nls-mCherry)ia17 and 
tg(BMPRE:GFP)ia18/(ins:dsRED)m1018, have been treated at 24 and 48 hpf for 4 days with a BMP 
inhibitor, LDN193189, and then observed at the confocal microscope.  
Notably, all the previously reported published data have been obtained through an early 
inhibition of this signal (not beyond early somitogenesis). Other signals can compensate for 
BMP inhibition and abolish or reduce BMP-mediated effect: retinoic acid positively regulates 
endocrine specification (Tehrani and Lin, 2011) and Notch and FGF signalling control endocrine 
progenitor differentiation (Ninov et al., 2012) (Norgaard et al., 2003).  
To complete the analysis of BMP influence on endocrine formation, the other cell types forming 
the pancreatic islets should be analysed: α-γ-δ-ε cells. In fact, it has been demonstrated that 
injection of BMP4-neutralizing antibodies slightly diminish the number of glucagon cells in 
adult mice (Hua and Sarvetnick, 2007).  
For what concerning the formation of the pancreatic vessel system, blocking BMP at early 
organogenesis (24 and 48 hpf) causes a defect in vessel branching. Notably, inhibition at 24 hpf 
leads to a decrease of kdrl-associated GFP. It seems that BMP signalling is important to 
maintain, but not to induce the formation of endocytes in newly-formed vessels. This is a direct 
effect of this signalling pathway on this cell type. In fact, mating tg(kdrl:GFP)la116 to 
tg(BMPER:nls-mCherry)ia17 lines it has been seen that BMP signalling is specifically active in 
endothelial cells. A 48 hpf inhibition of BMP signalling do not cause a depletion of endocytes. 
This seems to confirm the role of the signalling in the newly formed vessels.  
Notably, at both 24 and 48 hpf BMP seems to control angiogenesis. Blocking at 24 hpf cause an 
incomplete separation of the anterior mesenteric artery from the dorsal aorta. This process is later 
shifted in 48 hpf-treated larvae, even if the previously mentioned artery does not properly place. 
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In this case, abnormal branching is visible at 4 dpf. 
In conclusion, in early larval development BMP signalling seems to direct angiogenesis at least 
in pancreas. Specifically, it stabilizes the new vessels and it directs their positioning in the organ.  
The BMP activating source might be the islet itself. In fact, it has been produced and 
characterized a transgenic mouse that expresses the firefly luciferase gene under the control of 
Bmp4 promoter. The bioluminescence has been mainly identified in the pancreatic islets 
(Yasunaga et al., 2011). This may explain why the pancreatic islet fails to move if BMP pathway 
is inhibited.   
 
 
5. Conclusion: pros and cons of the use of reporter lines 
In this thesis four transgenic reporter lines have been proposed for in vivo study of BMP, TGFb, 
Wnt and Shh signalling pathways.  
Their validations demonstrate that they faithfully report the signalling for which they are 
responsive. The examples of in vivo study here described (pancreas, neurogenesis and epistasis) 
show how this model let us obtain and/or confirm new information concerning different 
physiological processes in a relatively easy way: the importance of BMP in the pancreatic 
vasculature development and the role of smad3 in neurogenesis. Notably, a large part of our 
results have been reached without sacrificing animals that can be an important advantage 
considering the restrictive laws for the experimental use of animal models. 
Furthermore, the in vivo study let us observe the organs development also in relation with 
chemical signals coming from adjacent tissues.  
Finally, the embryonic permeability to small molecules let us test some drugs acting on 
signalling involved in embryonic development and adult tissue homeostasis as well as in several 
diseases. Through these chemical treatments a scheme of putative epistatic relations has been 
proposed. Even if these interactions have to be further confirmed, they might represent a good 
starting-point for detailed analyses of tissue-specific pathways interactions. 
Nevertheless, nobody can consider as definitive the data obtained with reporter lines (Barolo, 
2006). All the results have to be confirmed through different approaches. Reporter lines are 
faithfully responsive, but they show only a part of each signalling. This become clearer if you 
consider the absence of Wnt-associated reporter in the pancreas contrasting to what has been 
observed in literature (Papadopoulou and Edlund, 2005) (Liu and Habener, 2010). 
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APPENDIX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S1. Different responsiveness of tg(12xSBE:nls-mCherry)ia15 line to smad2, smad3a, smad3b 
and smad4 morpholinos. Brightfield and fluorescent lateral images of smad2-, smad3a-, smad3b- and 
smad4-morphants at 24 hpf at the epifluorescent microscope, left to right. smad2, 3a and 3b morphants 
show a similar phenotype: anterior truncation, a curved shortened body axis, absence of floorplate and an 
enlarged intermediate cell mass. smad4 morphants have a worst phenotype: similar characteristics of the 
other morphants accompanied to a shortened dorsalyzed body due to BMP inhibition. mCherry 
expression is completely inhibited in smad4 and 3a morphants and strongly reduced in smad3b 
morphants. smad2 morphants lack reporter expression in the cardiac mesoderm and telencephalon like the 
other morphants (white arrow head) and display a mild reduction in the neural tube. 
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Fig. S2. 12xSBE lines have a similar expression pattern. Confocal lateral images of double transgenic 
tg(12xSBE:EGFP)ia16/tg(12xSBE:nls-mCherry)ia15 24 hpf embryo and 48 hpf larva, left to right. A-A'', 
anterior part of a 24 hpf double transgenic embryo: A, green channel; A', red channel; A'', merge; B-B'', 
tail of a 24 hpf double transgenic embryo: B, green channel; B', red channel; B'', merge; C-C'', anterior 
part of a 48 hpf double transgenic larva: C, green channel; C', red channel; C'', merge; D-D'', tail of a 24 
hpf double transgenic embryo: D, green channel; D', red channel; D'', merge.   
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Fig. S3. Confocal lateral images of brain and neural tube in double transgenic larvae 
tg(Ngn1:GFP)sb1/tg(12xSBE:nls-mCherry). Lateral view of head, hindbrain, trunk and tail in double 
transgenic larvae tg(Ngn1:GFP)sb1/tg(12xSBE:nls-mCherry) at 2, 3 and 4 dpf.  
 
 
 
 
 
 
 
 
 
 
 
 
104 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S4. Confocal lateral images of brain and nerural tube in double transgenic larvae 
tg(12xSBE:nls-mCherry)/tg(-2.4kb neurod:EGFP) or tg(gfap:GFP)mi20001. Lateral view of head, 
hindbrain, trunk and tail of double transgenic larvae tg(12xSBE:nls-mCherry)/tg(-2.4kb neurod:EGFP) or 
tg(gfap:GFP)mi20001  at 2, 3 and 4 dpf.  
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Fig. S5. Confocal lateral images of brain and nerural tube in double transgenic larvae 
tg(12xSBE:nls-mCherry)/ tg(Mnx1:GFP)ml2 and tg(Nkx2.2a:mGFP)vu17. Lateral view of head, 
hindbrain, trunk and tail of double transgenic larvae tg(12xSBE:nls-mCherry)/tg(Mnx1:GFP)ml2 and 
tg(Nkx2.2a:mGFP)vu17 at 2, 3 and 4 dpf.  
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Fig. S6. The effects of the inhibitors of the 4 morphogens on tg(12xSBE:EGFP)ia16, 
tg(BMPRE:EGFP)ia18, tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 lines: GFP 
expression.  Fluorescent lateral views of of tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, tg(12xGli-
Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 larvae  at 3 dpf. Each reporter line has been treated at 24 
hpf for 2 days with the inhibitors of the 4 morphogens (BMP, TGFb, Wnt and Shh).  
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Fig. S7. The effects of the other drugs tested on tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, 
tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 lines: GFP expression.  Fluorescent 
lateral views of tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-
Xla.Siam:GFP)ia4 larvae  at 3 dpf. Each reporter line has been treated at 24 hpf for 2 days with Wnt and 
Shh agonists and the inhibitors of Notch and FGF signalling pathways.  
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Fig. S8. The effects of the drugs tested on tg(Tp1bglob:eGFP) line: GFP expression.  Fluorescent 
lateral views of anterior and posterior body parts of tg(Tp1bglob:eGFP) larvae  at 3 dpf. This reporter line 
has been treated at 24 hpf for 2 days with drugs that alter Wnt, BMP, TGFb, Shh, FGF and Notch itself  
pathway.  
 
 
 
 
 
 
 
 
 
109 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S9. The effects of the drugs tested on 
tg(Tp1bglob:eGFP) line: GFP expression.  
Fluorescent lateral views of tg(Tp1bglob:eGFP) 
larvae  at 3 dpf. This reporter line has been 
treated at 24 hpf  for 2 days with drugs that alter 
Wnt, BMP, TGFb, Shh, FGF and Notch itself  
pathways. 
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Fig. S10. The effects of some of the 
drugs used for the epistasis study on  
tg(12xGli-Hsv.Tk:GFP)ia11 line: 
confocal observation.  Confocal views 
of heart, hindbrain (HB)-trunk and 
trunk of tg(12xGli-Hsv.Tk:GFP)ia11 
larvae  at 3 dpf.  
Fig. S11. The effects of FGF and Shh 
inhibitors on tg(7xTCF-
Xla.Siam:GFP)ia4 line: confocal 
observation.  Confocal views of heart 
and eye of tg(7xTCF-Xla.Siam:GFP)ia4 
larvae  at 3 dpf treated with 
cyclopamine (cyclo.), a Shh inhibitor, 
and SU5402, a FGF inhibitor.  
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Fig. S12. The effects of some of the 
drugs used for the epistasis study on 
tg(12xSBE:EGFP)ia16 line: confocal 
observation.  Confocal views of 
hindbrain (HB) and trunk of 
tg(12xSBE:EGFP)ia16 larvae  at 3 dpf.  
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Fig. S13. The effects of the inhibitors of the 4 morphogens on tg(12xSBE:EGFP)ia16, 
tg(BMPRE:EGFP)ia18, tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 lines: mRNA 
ISH for GFP expression.  Lateral views of of tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, tg(12xGli-
Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 larvae  at 3 dpf. Each reporter line has been treated at 24 
hpf for 2 days with the inhibitors of the 4 morphogens (BMP, TGFb, Wnt and Shh).  
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Fig. S14. The effects of the other drugs tested on tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, 
tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-Xla.Siam:GFP)ia4 lines: mRNA ISH for GFP expression.  
Lateral views of tg(12xSBE:EGFP)ia16, tg(BMPRE:EGFP)ia18, tg(12xGli-Hsv.Tk:GFP)ia11 and tg(7xTCF-
Xla.Siam:GFP)ia4 larvae  at 3 dpf. Each reporter line has been treated at 24 hpf for 2 days with Wnt and 
Shh agonists and the inhibitors of Notch and FGF signalling pathways.  
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Fig. S15. The effects of the drugs tested on tg(Tp1bglob:eGFP) line: mRNA ISH for GFP 
expression.  Lateral views of Tg(Tp1bglob:eGFP) larvae  at 3 dpf with magnified views of anterior and 
posterior body parts. This reporter line has been treated at 24 hpf for 2 days with drugs that alter Wnt, 
BMP, TGFb, Shh, FGF and Notch itself  pathway.  
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Fig. S16. Vessels make contact to beta-cells between 1 and 2 dpf.  Confocal stacks of double 
transgenic tg(ins:dsRED)m1018/(kdrl:GFP)la116 obtained through a time-laps observation between 1 and 
2 dpf.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S17. BMP signalling inhibition at 24 and 48 hpf causes a decrease of GFP-associated endocytes. 
Confocal magnified views of the pancreatic islet in the double transgenic  
tg(BMPRE:EGFP)ia18/(ins:dsRED)m1018 larvae treated at 1 and 2 dpf with an Alk2 and 3 inhibitor and 
observed at 3, 4 and 5 dpf. Treatment at 1 dpf decreases significantly kdrl-associated GFP expression in 
the islet region.   
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